ME02205B - INDUKUJUĆI AGENSI APOPTOZE ZA LEČENJE KANCERA I IMUNIH l AUTOIMUNIH OBOLJENJA - Google Patents
INDUKUJUĆI AGENSI APOPTOZE ZA LEČENJE KANCERA I IMUNIH l AUTOIMUNIH OBOLJENJAInfo
- Publication number
- ME02205B ME02205B MEP-2015-124A MEP12415A ME02205B ME 02205 B ME02205 B ME 02205B ME P12415 A MEP12415 A ME P12415A ME 02205 B ME02205 B ME 02205B
- Authority
- ME
- Montenegro
- Prior art keywords
- methyl
- pyridin
- sulfonyl
- yloxy
- pyrrolo
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title claims 2
- 230000006907 apoptotic process Effects 0.000 title 1
- 230000001363 autoimmune Effects 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 126
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 108
- -1 C(O)N(R1)2 Proteins 0.000 claims 100
- 101150009274 nhr-1 gene Proteins 0.000 claims 41
- 150000002390 heteroarenes Chemical class 0.000 claims 39
- 150000001924 cycloalkanes Chemical class 0.000 claims 35
- 150000001925 cycloalkenes Chemical class 0.000 claims 35
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 claims 32
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 claims 32
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims 30
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 28
- 125000000217 alkyl group Chemical group 0.000 claims 27
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 24
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 23
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 22
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 21
- 125000000753 cycloalkyl group Chemical group 0.000 claims 21
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 20
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 19
- 229910006074 SO2NH2 Inorganic materials 0.000 claims 19
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 19
- 125000001424 substituent group Chemical group 0.000 claims 18
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 16
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 15
- 125000001072 heteroaryl group Chemical group 0.000 claims 15
- 125000000304 alkynyl group Chemical group 0.000 claims 14
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 13
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 claims 13
- 101100294121 Caenorhabditis elegans nhr-57 gene Proteins 0.000 claims 12
- 125000004366 heterocycloalkenyl group Chemical group 0.000 claims 12
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 12
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 11
- 102220494498 Receptor of activated protein C kinase 1_R57A_mutation Human genes 0.000 claims 10
- 125000003342 alkenyl group Chemical group 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 9
- OTXBWGUYZNKPMG-UHFFFAOYSA-N isofulminic acid Chemical compound O[N+]#[C-] OTXBWGUYZNKPMG-UHFFFAOYSA-N 0.000 claims 9
- 101100516568 Caenorhabditis elegans nhr-7 gene Proteins 0.000 claims 6
- 125000004429 atom Chemical group 0.000 claims 6
- 125000004122 cyclic group Chemical group 0.000 claims 6
- 101100240518 Caenorhabditis elegans nhr-12 gene Proteins 0.000 claims 5
- 101100240527 Caenorhabditis elegans nhr-22 gene Proteins 0.000 claims 5
- 101100516557 Caenorhabditis elegans nhr-62 gene Proteins 0.000 claims 5
- 101100516560 Caenorhabditis elegans nhr-67 gene Proteins 0.000 claims 5
- 101100516561 Caenorhabditis elegans nhr-68 gene Proteins 0.000 claims 5
- 102220544041 60S ribosomal protein L27_R10A_mutation Human genes 0.000 claims 4
- 102220599428 Serum amyloid A-1 protein_R37A_mutation Human genes 0.000 claims 4
- WKULGVVLSQGJTK-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[(4-hydroxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCC(C)(O)CC1 WKULGVVLSQGJTK-UHFFFAOYSA-N 0.000 claims 3
- 102220586234 Chemerin-like receptor 2_R18A_mutation Human genes 0.000 claims 3
- 102220503849 Cortexin-1_R40A_mutation Human genes 0.000 claims 3
- 102220516986 Double homeobox protein 4_R23A_mutation Human genes 0.000 claims 3
- 102220503974 Endogenous retrovirus group K member 6 Rec protein_R13A_mutation Human genes 0.000 claims 3
- 102220642537 Gap junction alpha-8 protein_R28A_mutation Human genes 0.000 claims 3
- 102220507254 Rab11 family-interacting protein 1_R38K_mutation Human genes 0.000 claims 3
- 102220507255 Rab11 family-interacting protein 1_R39K_mutation Human genes 0.000 claims 3
- 125000004957 naphthylene group Chemical group 0.000 claims 3
- 102220497337 14-3-3 protein zeta/delta_R59A_mutation Human genes 0.000 claims 2
- HGCQJSCVVNLDMQ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[(4-ethyl-4-hydroxycyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CC(CC)(O)CCC1CNC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O HGCQJSCVVNLDMQ-UHFFFAOYSA-N 0.000 claims 2
- CSBKUBOVPUXFLO-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[(4-methoxycyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CC(OC)CCC1CNC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O CSBKUBOVPUXFLO-UHFFFAOYSA-N 0.000 claims 2
- NKITUFNNDFPWII-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[(4-morpholin-4-ylcyclohexyl)amino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCC1N1CCOCC1 NKITUFNNDFPWII-UHFFFAOYSA-N 0.000 claims 2
- RYUKEAYYUZJDNE-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[6-[(4-hydroxy-4-methylcyclohexyl)methylamino]-5-nitropyridin-3-yl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CN=C1NCC1CCC(C)(O)CC1 RYUKEAYYUZJDNE-UHFFFAOYSA-N 0.000 claims 2
- ADTUYXRNYHDWMP-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(4-hydroxy-4-methylcyclohexyl)methoxy]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC1CCC(C)(O)CC1 ADTUYXRNYHDWMP-UHFFFAOYSA-N 0.000 claims 2
- 102220542311 60S ribosomal protein L27_R19A_mutation Human genes 0.000 claims 2
- SVHMCCAITJLQTO-XXVZRKBMSA-N C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OC[C@H]1CC[C@H](O)CC1 Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OC[C@H]1CC[C@H](O)CC1 SVHMCCAITJLQTO-XXVZRKBMSA-N 0.000 claims 2
- 102220518322 Casein kinase I isoform gamma-2_R60A_mutation Human genes 0.000 claims 2
- 102220473072 Chemerin-like receptor 2_R14Q_mutation Human genes 0.000 claims 2
- 102220586235 Chemerin-like receptor 2_R63A_mutation Human genes 0.000 claims 2
- 102220586050 Chemerin-like receptor 2_R64A_mutation Human genes 0.000 claims 2
- 102220586191 Chemerin-like receptor 2_R65A_mutation Human genes 0.000 claims 2
- 102220474817 Chemerin-like receptor 2_R69A_mutation Human genes 0.000 claims 2
- 102220586055 Chemerin-like receptor 2_R70A_mutation Human genes 0.000 claims 2
- 102220598877 DNA-directed RNA polymerases I, II, and III subunit RPABC4_R15A_mutation Human genes 0.000 claims 2
- 102220503968 Endogenous retrovirus group K member 6 Rec protein_R20A_mutation Human genes 0.000 claims 2
- 102220555063 Holliday junction recognition protein_R25A_mutation Human genes 0.000 claims 2
- 102220595577 Major vault protein_R24A_mutation Human genes 0.000 claims 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims 2
- 102220544927 Nuclear pore complex protein Nup133_R30A_mutation Human genes 0.000 claims 2
- 102220507264 Rab11 family-interacting protein 1_R29A_mutation Human genes 0.000 claims 2
- 102220521126 Ribosome biogenesis protein NSA2 homolog_R58A_mutation Human genes 0.000 claims 2
- 102220521661 Ribosome biogenesis protein NSA2 homolog_R71A_mutation Human genes 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 2
- 125000006588 heterocycloalkylene group Chemical group 0.000 claims 2
- 208000014018 liver neoplasm Diseases 0.000 claims 2
- UQJOQWQMMPNGKT-UHFFFAOYSA-N n-[5-chloro-6-[(4-methoxycyclohexyl)methoxy]pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CC(OC)CCC1COC1=NC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1Cl UQJOQWQMMPNGKT-UHFFFAOYSA-N 0.000 claims 2
- 102200140336 rs786204767 Human genes 0.000 claims 2
- LQBVNQSMGBZMKD-UHFFFAOYSA-N venetoclax Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCOCC1 LQBVNQSMGBZMKD-UHFFFAOYSA-N 0.000 claims 2
- GLDXCBVHFHZTKV-UHFFFAOYSA-N 1-(3-methoxyphenyl)-2-phenylethane-1,2-dione Chemical compound COC1=CC=CC(C(=O)C(=O)C=2C=CC=CC=2)=C1 GLDXCBVHFHZTKV-UHFFFAOYSA-N 0.000 claims 1
- NTINAJCDYRYMML-UHFFFAOYSA-N 1-(4-methoxyphenyl)-2-phenylethane-1,2-dione Chemical compound C1=CC(OC)=CC=C1C(=O)C(=O)C1=CC=CC=C1 NTINAJCDYRYMML-UHFFFAOYSA-N 0.000 claims 1
- KXIXHISTUVHOCY-UHFFFAOYSA-N 1-propan-2-ylpiperidine Chemical compound CC(C)N1CCCCC1 KXIXHISTUVHOCY-UHFFFAOYSA-N 0.000 claims 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- NYUGGYOWSAFOBF-QQLMSYFVSA-N 4-[4-[[(1s,2r)-2-(4-chlorophenyl)-4,4-dimethylcyclohexyl]methyl]piperidin-1-yl]-n-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C([C@@H]1CCC(C[C@H]1C=1C=CC(Cl)=CC=1)(C)C)C(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCOCC1 NYUGGYOWSAFOBF-QQLMSYFVSA-N 0.000 claims 1
- JGIWGFDASVPCTP-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-[[4-(oxan-4-ylamino)cyclohexyl]amino]phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCC1NC1CCOCC1 JGIWGFDASVPCTP-UHFFFAOYSA-N 0.000 claims 1
- LEHOPKMTNLSQEY-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-[[4-[4-(oxan-4-yl)piperazin-1-yl]cyclohexyl]amino]phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCC1N(CC1)CCN1C1CCOCC1 LEHOPKMTNLSQEY-UHFFFAOYSA-N 0.000 claims 1
- FUGPWHUMYNZEGE-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[(4-methoxycyclohexyl)methoxy]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CC(OC)CCC1COC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O FUGPWHUMYNZEGE-UHFFFAOYSA-N 0.000 claims 1
- PBWXDNYODFLHSA-ZCXBXHLPSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(1R,4R,5R,6S)-5,6-dihydroxy-2-bicyclo[2.2.1]heptanyl]methoxy]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1C(C)(C)CCC(CN2CCN(CC2)C=2C=C(OC=3C=C4C=CNC4=NC=3)C(C(=O)NS(=O)(=O)C=3C=C(C(OCC4[C@H]5C[C@H]([C@H]([C@H]5O)O)C4)=CC=3)[N+]([O-])=O)=CC=2)=C1C1=CC=C(Cl)C=C1 PBWXDNYODFLHSA-ZCXBXHLPSA-N 0.000 claims 1
- PBWXDNYODFLHSA-WSVPCWEKSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(1R,4R,5S,6R)-5,6-dihydroxy-2-bicyclo[2.2.1]heptanyl]methoxy]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1C(C)(C)CCC(CN2CCN(CC2)C=2C=C(OC=3C=C4C=CNC4=NC=3)C(C(=O)NS(=O)(=O)C=3C=C(C(OCC4[C@H]5C[C@H]([C@@H]([C@@H]5O)O)C4)=CC=3)[N+]([O-])=O)=CC=2)=C1C1=CC=C(Cl)C=C1 PBWXDNYODFLHSA-WSVPCWEKSA-N 0.000 claims 1
- FODFFPZUZIECRM-MLZZNZMKSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(1S,3R)-3-morpholin-4-ylcyclopentyl]methylamino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound N1([C@@H]2CC[C@@H](C2)CNC2=CC=C(C=C2[N+]([O-])=O)S(=O)(=O)NC(=O)C2=CC=C(C=C2OC=2C=C3C=CNC3=NC=2)N2CCN(CC2)CC=2CCC(CC=2C=2C=CC(Cl)=CC=2)(C)C)CCOCC1 FODFFPZUZIECRM-MLZZNZMKSA-N 0.000 claims 1
- KBHSDAPEAXKGRS-DHUJRADRSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2S)-4,4-difluoro-1-(oxetan-3-yl)pyrrolidin-2-yl]methoxy]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C([C@H]1COC2=CC=C(C=C2[N+]([O-])=O)S(=O)(=O)NC(=O)C2=CC=C(C=C2OC=2C=C3C=CNC3=NC=2)N2CCN(CC2)CC=2CCC(CC=2C=2C=CC(Cl)=CC=2)(C)C)C(F)(F)CN1C1COC1 KBHSDAPEAXKGRS-DHUJRADRSA-N 0.000 claims 1
- FVNUQXJSDSXEBR-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[1-(1,3-difluoropropan-2-yl)azetidin-3-yl]methylamino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CN(C(CF)CF)C1 FVNUQXJSDSXEBR-UHFFFAOYSA-N 0.000 claims 1
- XWCZPKOOJKYCEC-KOHORPAVSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[1-[(3R,4R)-3-fluorooxan-4-yl]piperidin-4-yl]amino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCN1[C@@H]1CCOC[C@@H]1F XWCZPKOOJKYCEC-KOHORPAVSA-N 0.000 claims 1
- PKOJKTGPUOKMCZ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[4-(cyclopropylamino)cyclohexyl]amino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCC1NC1CC1 PKOJKTGPUOKMCZ-UHFFFAOYSA-N 0.000 claims 1
- XCEYFIPGAZZSPS-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[4-(dicyclopropylamino)cyclohexyl]amino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCC1N(C1CC1)C1CC1 XCEYFIPGAZZSPS-UHFFFAOYSA-N 0.000 claims 1
- CZWPSARPAPGCSA-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[4-(methanesulfonamido)cyclohexyl]amino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC1CCC(NS(C)(=O)=O)CC1 CZWPSARPAPGCSA-UHFFFAOYSA-N 0.000 claims 1
- KNVQPTSRJUELFP-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[4-[2-cyanoethyl(cyclopropyl)amino]cyclohexyl]amino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCC1N(CCC#N)C1CC1 KNVQPTSRJUELFP-UHFFFAOYSA-N 0.000 claims 1
- WXOWXNJJXWISMF-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[(4-oxo-1h-quinazolin-6-yl)sulfonyl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1C(C)(C)CCC(CN2CCN(CC2)C=2C=C(OC=3C=C4C=CNC4=NC=3)C(C(=O)NS(=O)(=O)C=3C=C4C(=O)NC=NC4=CC=3)=CC=2)=C1C1=CC=C(Cl)C=C1 WXOWXNJJXWISMF-UHFFFAOYSA-N 0.000 claims 1
- ZTSWUGGZENHBNL-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-cyano-4-(oxan-4-ylmethoxy)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1C#N)=CC=C1OCC1CCOCC1 ZTSWUGGZENHBNL-UHFFFAOYSA-N 0.000 claims 1
- RMUGSEJQYOHCKD-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-cyano-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1C#N)=CC=C1NCC1CCOCC1 RMUGSEJQYOHCKD-UHFFFAOYSA-N 0.000 claims 1
- YGXOOIXZEQFHSN-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(2,2,2-trifluoroethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C1=CC=C(NCC(F)(F)F)C([N+]([O-])=O)=C1 YGXOOIXZEQFHSN-UHFFFAOYSA-N 0.000 claims 1
- OVDFETFTUQPQFG-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(2-oxaspiro[3.5]nonan-7-ylmethoxy)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC(CC1)CCC21COC2 OVDFETFTUQPQFG-UHFFFAOYSA-N 0.000 claims 1
- KZFSLJUCIKSUAM-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(2-oxaspiro[3.5]nonan-7-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC(CC1)CCC21COC2 KZFSLJUCIKSUAM-UHFFFAOYSA-N 0.000 claims 1
- MOSZSOAPGWWZGM-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(3,3,3-trifluoropropylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C1=CC=C(NCCC(F)(F)F)C([N+]([O-])=O)=C1 MOSZSOAPGWWZGM-UHFFFAOYSA-N 0.000 claims 1
- SWTUOVBEIYFQAW-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(oxan-4-ylmethoxy)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC1CCOCC1 SWTUOVBEIYFQAW-UHFFFAOYSA-N 0.000 claims 1
- CBXJUICVQCIXKO-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(oxolan-3-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCOC1 CBXJUICVQCIXKO-UHFFFAOYSA-N 0.000 claims 1
- LNWIKALYDRCZHA-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-[(3-oxocyclohexyl)methoxy]phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC1CCCC(=O)C1 LNWIKALYDRCZHA-UHFFFAOYSA-N 0.000 claims 1
- SMRFFBSYMPJNSJ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-[2-(oxolan-3-yloxy)ethoxy]phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCCOC1CCOC1 SMRFFBSYMPJNSJ-UHFFFAOYSA-N 0.000 claims 1
- LTQSONOIEBRYPY-JGCGQSQUSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-[[(3r)-oxolan-3-yl]amino]phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1N[C@@H]1CCOC1 LTQSONOIEBRYPY-JGCGQSQUSA-N 0.000 claims 1
- MEKVNOOLCRQDHA-LHEWISCISA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-[[(3s)-2-oxopiperidin-3-yl]amino]phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1N[C@H]1CCCNC1=O MEKVNOOLCRQDHA-LHEWISCISA-N 0.000 claims 1
- TZAYFMBZFWSUCQ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-[[1-(oxan-4-yl)azetidin-3-yl]amino]phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(C1)CN1C1CCOCC1 TZAYFMBZFWSUCQ-UHFFFAOYSA-N 0.000 claims 1
- DHEHLTGGZQAKJX-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-[[1-(oxetan-3-yl)azetidin-3-yl]amino]phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(C1)CN1C1COC1 DHEHLTGGZQAKJX-UHFFFAOYSA-N 0.000 claims 1
- AZIUZWNRHASVGU-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-[[1-(oxetan-3-yl)piperidin-4-yl]amino]phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCN1C1COC1 AZIUZWNRHASVGU-UHFFFAOYSA-N 0.000 claims 1
- ARDFMFLYKPWMQB-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-[[1-(oxetan-3-yl)piperidin-4-yl]methoxy]phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC(CC1)CCN1C1COC1 ARDFMFLYKPWMQB-UHFFFAOYSA-N 0.000 claims 1
- ZTSILJRQJRBECW-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-[[3-(trifluoromethoxy)phenyl]methylamino]phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1=CC=CC(OC(F)(F)F)=C1 ZTSILJRQJRBECW-UHFFFAOYSA-N 0.000 claims 1
- XKEXBWKWKBRKKV-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-[[4-(oxetan-3-yl)piperazin-1-yl]amino]phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NN(CC1)CCN1C1COC1 XKEXBWKWKBRKKV-UHFFFAOYSA-N 0.000 claims 1
- XPJQWWCHHLBCCH-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(1,4-dioxan-2-ylmethoxy)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC1COCCO1 XPJQWWCHHLBCCH-UHFFFAOYSA-N 0.000 claims 1
- UWFNVICMJXECTL-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(1,4-dioxan-2-ylmethylamino)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1COCCO1 UWFNVICMJXECTL-UHFFFAOYSA-N 0.000 claims 1
- UMHANGCMNUIVTH-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(1,4-dioxaspiro[4.5]decan-8-ylamino)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCC21OCCO2 UMHANGCMNUIVTH-UHFFFAOYSA-N 0.000 claims 1
- ARVNTYAWJFCNBT-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(2-cyanoethylamino)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C1=CC=C(NCCC#N)C([N+]([O-])=O)=C1 ARVNTYAWJFCNBT-UHFFFAOYSA-N 0.000 claims 1
- SGFNZHPUMCITBS-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(2-methoxyethylamino)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1=C([N+]([O-])=O)C(NCCOC)=CC=C1S(=O)(=O)NC(=O)C1=CC=C(N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)C=C1OC1=CN=C(NC=C2)C2=C1 SGFNZHPUMCITBS-UHFFFAOYSA-N 0.000 claims 1
- XNTSJCOLINDAQV-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(3-morpholin-4-ylpropylamino)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCCCN1CCOCC1 XNTSJCOLINDAQV-UHFFFAOYSA-N 0.000 claims 1
- HBVLATBANSZADQ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(4-morpholin-4-ylbut-2-ynoxy)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC#CCN1CCOCC1 HBVLATBANSZADQ-UHFFFAOYSA-N 0.000 claims 1
- UDFKZHVUMFTJKD-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(furan-3-ylmethoxy)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC=1C=COC=1 UDFKZHVUMFTJKD-UHFFFAOYSA-N 0.000 claims 1
- LGHVXUGTPXYGCJ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(morpholin-2-ylmethylamino)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CNCCO1 LGHVXUGTPXYGCJ-UHFFFAOYSA-N 0.000 claims 1
- SHPUGOCWFSTEOI-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(morpholin-3-ylmethoxy)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC1COCCN1 SHPUGOCWFSTEOI-UHFFFAOYSA-N 0.000 claims 1
- WXLXUGGDJKYDGY-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-(morpholin-3-ylmethylamino)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1COCCN1 WXLXUGGDJKYDGY-UHFFFAOYSA-N 0.000 claims 1
- OSLAVZCRQFLYSE-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)amino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NN1CCS(=O)(=O)CC1 OSLAVZCRQFLYSE-UHFFFAOYSA-N 0.000 claims 1
- JCBRSOXUSORGLN-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(1-cyclobutylpiperidin-4-yl)amino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCN1C1CCC1 JCBRSOXUSORGLN-UHFFFAOYSA-N 0.000 claims 1
- SRHILRZQJUGSGX-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(1-cyclopropylpiperidin-4-yl)amino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCN1C1CC1 SRHILRZQJUGSGX-UHFFFAOYSA-N 0.000 claims 1
- YNQNZAUOVAYQCE-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(1-methyl-5-oxopyrrolidin-3-yl)amino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1C(=O)N(C)CC1NC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O YNQNZAUOVAYQCE-UHFFFAOYSA-N 0.000 claims 1
- VWFUWKGATFWYJU-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(1-methylpiperidin-4-yl)amino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C)CCC1NC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O VWFUWKGATFWYJU-UHFFFAOYSA-N 0.000 claims 1
- YYCSXFRYHHWHHR-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(1-methylpiperidin-4-yl)methoxy]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C)CCC1COC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O YYCSXFRYHHWHHR-UHFFFAOYSA-N 0.000 claims 1
- YIWCJRDYDWHTFY-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(1-methylpiperidin-4-yl)methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C)CCC1CNC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O YIWCJRDYDWHTFY-UHFFFAOYSA-N 0.000 claims 1
- RSMQQIHISLSANF-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(1-methylsulfonylpiperidin-4-yl)amino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC1CCN(S(C)(=O)=O)CC1 RSMQQIHISLSANF-UHFFFAOYSA-N 0.000 claims 1
- VMTHNVBTTVZZPT-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(3-hydroxy-2,2-dimethylpropyl)amino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1=C([N+]([O-])=O)C(NCC(C)(CO)C)=CC=C1S(=O)(=O)NC(=O)C1=CC=C(N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)C=C1OC1=CN=C(NC=C2)C2=C1 VMTHNVBTTVZZPT-UHFFFAOYSA-N 0.000 claims 1
- XSRSQZAQKMDUBK-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(3-hydroxyphenyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1=CC=CC(O)=C1 XSRSQZAQKMDUBK-UHFFFAOYSA-N 0.000 claims 1
- BFSOHRWRNSMSCH-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(3-methoxy-2,2-dimethylpropyl)amino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1=C([N+]([O-])=O)C(NCC(C)(C)COC)=CC=C1S(=O)(=O)NC(=O)C1=CC=C(N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)C=C1OC1=CN=C(NC=C2)C2=C1 BFSOHRWRNSMSCH-UHFFFAOYSA-N 0.000 claims 1
- AIKCIHDUQPPUKD-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(4,4-difluorocyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCC(F)(F)CC1 AIKCIHDUQPPUKD-UHFFFAOYSA-N 0.000 claims 1
- MDUWKIAFAXTWRQ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(4-fluoropiperidin-4-yl)methoxy]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC1(F)CCNCC1 MDUWKIAFAXTWRQ-UHFFFAOYSA-N 0.000 claims 1
- BRQXNCXWHXCDPA-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(4-hydroxy-1-adamantyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1C(C)(C)CCC(CN2CCN(CC2)C=2C=C(OC=3C=C4C=CNC4=NC=3)C(C(=O)NS(=O)(=O)C=3C=C(C(NCC45CC6CC(CC(C6O)C5)C4)=CC=3)[N+]([O-])=O)=CC=2)=C1C1=CC=C(Cl)C=C1 BRQXNCXWHXCDPA-UHFFFAOYSA-N 0.000 claims 1
- ZGMXABATFPPKSZ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(4-hydroxyphenyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1=CC=C(O)C=C1 ZGMXABATFPPKSZ-UHFFFAOYSA-N 0.000 claims 1
- OYBAZZOEJSIHOL-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(4-methylmorpholin-2-yl)methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1N(C)CCOC1CNC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O OYBAZZOEJSIHOL-UHFFFAOYSA-N 0.000 claims 1
- QANMVQFCTLIVEG-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[(4-methylpiperazin-1-yl)amino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C)CCN1NC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O QANMVQFCTLIVEG-UHFFFAOYSA-N 0.000 claims 1
- MTYZNVLVSZYNFF-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[2-(2-methoxyethoxy)ethylsulfonyl]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1=C([N+]([O-])=O)C(S(=O)(=O)CCOCCOC)=CC=C1S(=O)(=O)NC(=O)C1=CC=C(N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)C=C1OC1=CN=C(NC=C2)C2=C1 MTYZNVLVSZYNFF-UHFFFAOYSA-N 0.000 claims 1
- UDUHXXIMBIIODO-UYHPJTEGSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[[(1r,3s)-3-hydroxycyclopentyl]methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC[C@@H]1CC[C@H](O)C1 UDUHXXIMBIIODO-UYHPJTEGSA-N 0.000 claims 1
- UDUHXXIMBIIODO-WHMAPKLYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[[(1s,3r)-3-hydroxycyclopentyl]methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC[C@H]1CC[C@@H](O)C1 UDUHXXIMBIIODO-WHMAPKLYSA-N 0.000 claims 1
- XPJQWWCHHLBCCH-PGUFJCEWSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[[(2r)-1,4-dioxan-2-yl]methoxy]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OC[C@H]1COCCO1 XPJQWWCHHLBCCH-PGUFJCEWSA-N 0.000 claims 1
- XPJQWWCHHLBCCH-DHUJRADRSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[[(2s)-1,4-dioxan-2-yl]methoxy]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OC[C@@H]1COCCO1 XPJQWWCHHLBCCH-DHUJRADRSA-N 0.000 claims 1
- GKIAOZKGAIQVBO-OIDHKYIRSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[[(3r,4r)-4-(fluoromethyl)-1-(oxetan-3-yl)pyrrolidin-3-yl]methoxy]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C([C@@H]([C@H](C1)CF)COC2=CC=C(C=C2[N+]([O-])=O)S(=O)(=O)NC(=O)C2=CC=C(C=C2OC=2C=C3C=CNC3=NC=2)N2CCN(CC2)CC=2CCC(CC=2C=2C=CC(Cl)=CC=2)(C)C)N1C1COC1 GKIAOZKGAIQVBO-OIDHKYIRSA-N 0.000 claims 1
- CPJKVMMOTLMSSY-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[[3-(difluoromethoxy)phenyl]methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1=CC=CC(OC(F)F)=C1 CPJKVMMOTLMSSY-UHFFFAOYSA-N 0.000 claims 1
- FYVUBEVHOYSEBP-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[[4-(difluoromethoxy)phenyl]methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1=CC=C(OC(F)F)C=C1 FYVUBEVHOYSEBP-UHFFFAOYSA-N 0.000 claims 1
- OBDIOCGTOVVKBJ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[4-[[4-fluoro-1-(oxetan-3-yl)piperidin-4-yl]methoxy]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC(CC1)(F)CCN1C1COC1 OBDIOCGTOVVKBJ-UHFFFAOYSA-N 0.000 claims 1
- YYYRZMJZVXGSKG-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[5-cyano-6-(1,4-dioxan-2-ylmethoxy)pyridin-3-yl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1C#N)=CN=C1OCC1COCCO1 YYYRZMJZVXGSKG-UHFFFAOYSA-N 0.000 claims 1
- IYJJTGJTNSOTQA-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[5-cyano-6-(oxan-4-ylmethoxy)pyridin-3-yl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1C#N)=CN=C1OCC1CCOCC1 IYJJTGJTNSOTQA-UHFFFAOYSA-N 0.000 claims 1
- QUEPNEUDQZDVFB-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[5-cyano-6-[(4-morpholin-4-ylcyclohexyl)amino]pyridin-3-yl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1C#N)=CN=C1NC(CC1)CCC1N1CCOCC1 QUEPNEUDQZDVFB-UHFFFAOYSA-N 0.000 claims 1
- LPXYSNAJZKBWBC-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[5-ethynyl-6-(oxan-4-ylmethoxy)pyridin-3-yl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1C#C)=CN=C1OCC1CCOCC1 LPXYSNAJZKBWBC-UHFFFAOYSA-N 0.000 claims 1
- VPCQNTSGSDBEGN-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[5-fluoro-6-(oxan-4-ylmethoxy)pyridin-3-yl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1F)=CN=C1OCC1CCOCC1 VPCQNTSGSDBEGN-UHFFFAOYSA-N 0.000 claims 1
- PDFGQOUGJMWTIA-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[6-[(4-fluorooxan-4-yl)methoxy]pyridin-3-yl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=N1)=CC=C1OCC1(F)CCOCC1 PDFGQOUGJMWTIA-UHFFFAOYSA-N 0.000 claims 1
- AEVKJILLYZBTBT-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-naphthalen-2-ylsulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1C(C)(C)CCC(CN2CCN(CC2)C=2C=C(OC=3C=C4C=CNC4=NC=3)C(C(=O)NS(=O)(=O)C=3C=C4C=CC=CC4=CC=3)=CC=2)=C1C1=CC=C(Cl)C=C1 AEVKJILLYZBTBT-UHFFFAOYSA-N 0.000 claims 1
- YXSRAWIUHWKKHX-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperidin-1-yl]-n-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CC(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCOCC1 YXSRAWIUHWKKHX-UHFFFAOYSA-N 0.000 claims 1
- ORQVWASBAMIFHZ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-5,5-difluorocyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CC(F)(F)CCC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)=CC=C1NCC1CCOCC1 ORQVWASBAMIFHZ-UHFFFAOYSA-N 0.000 claims 1
- RTVNBRWRPBHVKL-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1C(C)(C)CCC(C=2C=CC(Cl)=CC=2)=C1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCOCC1 RTVNBRWRPBHVKL-UHFFFAOYSA-N 0.000 claims 1
- SIMDXFWGMPLGLA-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[5-cyano-6-(oxan-4-ylmethoxy)pyridin-3-yl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1C(C)(C)CCC(C=2C=CC(Cl)=CC=2)=C1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1C#N)=CN=C1OCC1CCOCC1 SIMDXFWGMPLGLA-UHFFFAOYSA-N 0.000 claims 1
- OUUANQIXKOTMKG-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-5-methoxy-5-methylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[(4-hydroxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1C(OC)(C)CCC(C=2C=CC(Cl)=CC=2)=C1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCC(C)(O)CC1 OUUANQIXKOTMKG-UHFFFAOYSA-N 0.000 claims 1
- LXEAMSGDMHPGRJ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)-6,6-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound CC1(C)CCCC(C=2C=CC(Cl)=CC=2)=C1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCOCC1 LXEAMSGDMHPGRJ-UHFFFAOYSA-N 0.000 claims 1
- JTUKXKJWRQZHBJ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)phenyl]methyl]-4-fluoropiperidin-1-yl]-n-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCC(F)(CC=3C(=CC=CC=3)C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)=CC=C1NCC1CCOCC1 JTUKXKJWRQZHBJ-UHFFFAOYSA-N 0.000 claims 1
- RPMQNDHUVHPJEJ-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)phenyl]methyl]-4-methoxypiperidin-1-yl]-n-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C=2C=C(OC=3C=C4C=CNC4=NC=3)C(C(=O)NS(=O)(=O)C=3C=C(C(NCC4CCOCC4)=CC=3)[N+]([O-])=O)=CC=2)CCC1(OC)CC1=CC=CC=C1C1=CC=C(Cl)C=C1 RPMQNDHUVHPJEJ-UHFFFAOYSA-N 0.000 claims 1
- HTGMQMQNQOJMDP-UHFFFAOYSA-N 4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]-n-[4-(3-morpholin-4-ylpropylamino)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3C(=CC=CC=3)C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)=CC=C1NCCCN1CCOCC1 HTGMQMQNQOJMDP-UHFFFAOYSA-N 0.000 claims 1
- XBANGVMCIRMPAC-UHFFFAOYSA-N 4-[4-[[4-(4-chlorophenyl)-6,6-dimethyl-2,5-dihydropyran-3-yl]methyl]piperazin-1-yl]-N-[4-[(4-morpholin-4-ylcyclohexyl)amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1OC(C)(C)CC(C=2C=CC(Cl)=CC=2)=C1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1S(=O)(=O)C(F)(F)F)=CC=C1NC(CC1)CCC1N1CCOCC1 XBANGVMCIRMPAC-UHFFFAOYSA-N 0.000 claims 1
- BEABEHQNCJQGIZ-UHFFFAOYSA-N 4-[4-[[4-(4-chlorophenyl)-6,6-dimethyl-2,5-dihydropyran-3-yl]methyl]piperazin-1-yl]-N-[4-[(4-morpholin-4-ylcyclohexyl)amino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1OC(C)(C)CC(C=2C=CC(Cl)=CC=2)=C1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCC1N1CCOCC1 BEABEHQNCJQGIZ-UHFFFAOYSA-N 0.000 claims 1
- YTJIPEBOUNOIQY-UHFFFAOYSA-N 4-[4-[[4-(4-chlorophenyl)-6,6-dimethyl-2,5-dihydropyran-3-yl]methyl]piperazin-1-yl]-n-[4-(1,4-dioxan-2-ylmethoxy)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1OC(C)(C)CC(C=2C=CC(Cl)=CC=2)=C1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1OCC1COCCO1 YTJIPEBOUNOIQY-UHFFFAOYSA-N 0.000 claims 1
- GFMKMTGNPITHHW-UHFFFAOYSA-N 4-[4-[[4-(4-chlorophenyl)-6,6-dimethyl-2,5-dihydropyran-3-yl]methyl]piperazin-1-yl]-n-[4-(1,4-dioxan-2-ylmethylamino)-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1OC(C)(C)CC(C=2C=CC(Cl)=CC=2)=C1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1COCCO1 GFMKMTGNPITHHW-UHFFFAOYSA-N 0.000 claims 1
- HSIPILLOKFOTJP-UHFFFAOYSA-N 4-[4-[[4-(4-chlorophenyl)-6,6-dimethyl-2,5-dihydropyran-3-yl]methyl]piperazin-1-yl]-n-[4-[(4-methoxycyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CC(OC)CCC1CNC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3COC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O HSIPILLOKFOTJP-UHFFFAOYSA-N 0.000 claims 1
- ITFBGCIOSFQLSO-UHFFFAOYSA-N 4-[4-[[4-(4-chlorophenyl)-6,6-dimethyl-2,5-dihydropyran-3-yl]methyl]piperazin-1-yl]-n-[4-[(4-methylpiperazin-1-yl)amino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C)CCN1NC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3COC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O ITFBGCIOSFQLSO-UHFFFAOYSA-N 0.000 claims 1
- RZBKSAZIPWCEIT-UHFFFAOYSA-N 4-[4-[[7-(4-chlorophenyl)spiro[2.5]oct-6-en-6-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC4(CC4)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)=CC=C1NCC1CCOCC1 RZBKSAZIPWCEIT-UHFFFAOYSA-N 0.000 claims 1
- FUGZXRLAUJHXHV-UHFFFAOYSA-N 4-[4-[[7-(4-chlorophenyl)spiro[2.5]oct-6-en-6-yl]methyl]piperazin-1-yl]-n-[4-[(4-cyclopropylmorpholin-2-yl)methylamino]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC4(CC4)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)=CC=C1NCC(OCC1)CN1C1CC1 FUGZXRLAUJHXHV-UHFFFAOYSA-N 0.000 claims 1
- OVDYVCQUVWIKBD-UHFFFAOYSA-N 4-[4-[[8-(4-chlorophenyl)spiro[4.5]dec-8-en-9-yl]methyl]piperazin-1-yl]-N-[4-[(4-methoxycyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CC(OC)CCC1CNC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CC4(CCCC4)CCC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O OVDYVCQUVWIKBD-UHFFFAOYSA-N 0.000 claims 1
- NHLHWDQURAWPSF-UHFFFAOYSA-N 4-[4-[[8-(4-chlorophenyl)spiro[4.5]dec-8-en-9-yl]methyl]piperazin-1-yl]-n-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CC4(CCCC4)CCC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)=CC=C1NCC1CCOCC1 NHLHWDQURAWPSF-UHFFFAOYSA-N 0.000 claims 1
- IRLACFOOYCCBPL-UHFFFAOYSA-N 4-[4-[[8-(4-chlorophenyl)spiro[4.5]dec-8-en-9-yl]methyl]piperazin-1-yl]-n-[4-[(4-fluorooxan-4-yl)methoxy]-3-nitrophenyl]sulfonyl-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CC4(CCCC4)CCC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)=CC=C1OCC1(F)CCOCC1 IRLACFOOYCCBPL-UHFFFAOYSA-N 0.000 claims 1
- PPDVKOJDTOQWBU-UHFFFAOYSA-N 4-cyclopropylmorpholine Chemical compound C1CC1N1CCOCC1 PPDVKOJDTOQWBU-UHFFFAOYSA-N 0.000 claims 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 claims 1
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- FUGPWHUMYNZEGE-KBMXFRJJSA-N C1C[C@H](OC)CC[C@@H]1COC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O Chemical compound C1C[C@H](OC)CC[C@@H]1COC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O FUGPWHUMYNZEGE-KBMXFRJJSA-N 0.000 claims 1
- ZJXQKAWLVOIGLM-XXVZRKBMSA-N C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CC=C1OC[C@H]1CC[C@H](O)CC1 Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CC=C1OC[C@H]1CC[C@H](O)CC1 ZJXQKAWLVOIGLM-XXVZRKBMSA-N 0.000 claims 1
- KMWVKROCNREHOD-MHVDQYQOSA-N C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CN=C1OC[C@H]1CC[C@H](O)CC1 Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CN=C1OC[C@H]1CC[C@H](O)CC1 KMWVKROCNREHOD-MHVDQYQOSA-N 0.000 claims 1
- CKEDDJRMVZKPDQ-UEOVJWFCSA-N C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC[C@H]1CC[C@H](C#N)CC1 Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC[C@H]1CC[C@H](C#N)CC1 CKEDDJRMVZKPDQ-UEOVJWFCSA-N 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims 1
- 208000003445 Mouth Neoplasms Diseases 0.000 claims 1
- WBWGIQPTCQYYQV-UHFFFAOYSA-N N-[3-chloro-4-[(4-hydroxy-4-methylcyclohexyl)methoxy]phenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CC=C1OCC1CCC(C)(O)CC1 WBWGIQPTCQYYQV-UHFFFAOYSA-N 0.000 claims 1
- LIZHBRQNCSPNPN-UHFFFAOYSA-N N-[4-[(4-acetamidocyclohexyl)amino]-3-nitrophenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CC(NC(=O)C)CCC1NC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O LIZHBRQNCSPNPN-UHFFFAOYSA-N 0.000 claims 1
- GHGQHMWYLJSPHL-UHFFFAOYSA-N N-[4-[[4-[bis(cyclopropylmethyl)amino]cyclohexyl]amino]-3-nitrophenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NC(CC1)CCC1N(CC1CC1)CC1CC1 GHGQHMWYLJSPHL-UHFFFAOYSA-N 0.000 claims 1
- HAPIOUDNCDBOIB-UHFFFAOYSA-N N-[5-chloro-6-[(1-fluoro-4-hydroxycyclohexyl)methoxy]pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CN=C1OCC1(F)CCC(O)CC1 HAPIOUDNCDBOIB-UHFFFAOYSA-N 0.000 claims 1
- JHPHSPYSBGEZFM-UHFFFAOYSA-N N-[5-chloro-6-[(4-hydroxy-4-methylcyclohexyl)methoxy]pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CN=C1OCC1CCC(C)(O)CC1 JHPHSPYSBGEZFM-UHFFFAOYSA-N 0.000 claims 1
- 108091008648 NR7C Proteins 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 101100212791 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YBL068W-A gene Proteins 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- KQHBVBJHHZFRTR-UVATWBARSA-N [O-][N+](=O)c1cc(ccc1N[C@H]1CC[C@@H](CC1)N1CCOCC1)S(=O)(=O)NC(=O)c1ccc(cc1Oc1cnc2[nH]ccc2c1)N1CCN(CC2=C(CCC3(CCCC3)C2)c2ccc(Cl)cc2)CC1 Chemical compound [O-][N+](=O)c1cc(ccc1N[C@H]1CC[C@@H](CC1)N1CCOCC1)S(=O)(=O)NC(=O)c1ccc(cc1Oc1cnc2[nH]ccc2c1)N1CCN(CC2=C(CCC3(CCCC3)C2)c2ccc(Cl)cc2)CC1 KQHBVBJHHZFRTR-UVATWBARSA-N 0.000 claims 1
- 125000004450 alkenylene group Chemical group 0.000 claims 1
- 125000004419 alkynylene group Chemical group 0.000 claims 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims 1
- 101150117004 atg18 gene Proteins 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 201000006491 bone marrow cancer Diseases 0.000 claims 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims 1
- 125000005724 cycloalkenylene group Chemical group 0.000 claims 1
- 125000002993 cycloalkylene group Chemical group 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- PVSDCKZNCMWEBM-UHFFFAOYSA-N ethyl 4-[4-[[4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzoyl]sulfamoyl]-2-nitrophenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCN1C1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O PVSDCKZNCMWEBM-UHFFFAOYSA-N 0.000 claims 1
- 201000003444 follicular lymphoma Diseases 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 125000005549 heteroarylene group Chemical group 0.000 claims 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000003747 lymphoid leukemia Diseases 0.000 claims 1
- 230000036210 malignancy Effects 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- ZKWFSTHEYLJLEL-UHFFFAOYSA-N morpholine-4-carboxamide Chemical compound NC(=O)N1CCOCC1 ZKWFSTHEYLJLEL-UHFFFAOYSA-N 0.000 claims 1
- 208000025113 myeloid leukemia Diseases 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- WPBAGEORUIRGMF-UHFFFAOYSA-N n-[3-carbamoyl-4-(oxan-4-ylmethoxy)phenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1C(N)=O)=CC=C1OCC1CCOCC1 WPBAGEORUIRGMF-UHFFFAOYSA-N 0.000 claims 1
- DTJMFKPTDKWWTE-UHFFFAOYSA-N n-[3-chloro-4-(oxan-4-ylmethoxy)phenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperidin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CC(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CC=C1OCC1CCOCC1 DTJMFKPTDKWWTE-UHFFFAOYSA-N 0.000 claims 1
- QFRVJWHHCKIPLD-UHFFFAOYSA-N n-[3-chloro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CC=C1NCC1CCOCC1 QFRVJWHHCKIPLD-UHFFFAOYSA-N 0.000 claims 1
- SIQONKZGLLDYCT-UHFFFAOYSA-N n-[3-chloro-4-(oxolan-3-ylmethoxy)phenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CC=C1OCC1CCOC1 SIQONKZGLLDYCT-UHFFFAOYSA-N 0.000 claims 1
- XBGZQNUPLNXBDI-UHFFFAOYSA-N n-[3-chloro-4-[(4-cyclopropylmorpholin-2-yl)methoxy]phenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CC=C1OCC(OCC1)CN1C1CC1 XBGZQNUPLNXBDI-UHFFFAOYSA-N 0.000 claims 1
- DDMMWMQDMZMMMO-UHFFFAOYSA-N n-[3-chloro-4-[(4-fluoro-1-methylpiperidin-4-yl)methoxy]phenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C)CCC1(F)COC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1Cl DDMMWMQDMZMMMO-UHFFFAOYSA-N 0.000 claims 1
- IJRJSPSMXYYCDR-UHFFFAOYSA-N n-[3-chloro-4-[2-(2-methoxyethoxy)ethylsulfonyl]phenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1=C(Cl)C(S(=O)(=O)CCOCCOC)=CC=C1S(=O)(=O)NC(=O)C1=CC=C(N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)C=C1OC1=CN=C(NC=C2)C2=C1 IJRJSPSMXYYCDR-UHFFFAOYSA-N 0.000 claims 1
- WJLXRPRGWNCTHK-UHFFFAOYSA-N n-[3-chloro-4-[[1-(2-methoxyacetyl)piperidin-4-yl]methoxy]phenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C(=O)COC)CCC1COC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1Cl WJLXRPRGWNCTHK-UHFFFAOYSA-N 0.000 claims 1
- MONFKNTWTDORSO-UHFFFAOYSA-N n-[3-chloro-4-[[1-(oxetan-3-yl)piperidin-4-yl]methoxy]phenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CC=C1OCC(CC1)CCN1C1COC1 MONFKNTWTDORSO-UHFFFAOYSA-N 0.000 claims 1
- CXPKOPQMDKGHBE-UHFFFAOYSA-N n-[4-[(1-acetylpiperidin-4-yl)amino]-3-nitrophenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C(=O)C)CCC1NC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O CXPKOPQMDKGHBE-UHFFFAOYSA-N 0.000 claims 1
- RPCVRDXNWINENN-UHFFFAOYSA-N n-[4-[(1-tert-butylpiperidin-4-yl)amino]-3-nitrophenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C(C)(C)C)CCC1NC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O RPCVRDXNWINENN-UHFFFAOYSA-N 0.000 claims 1
- AWQBEZQZXIAGFK-UHFFFAOYSA-N n-[4-[(4-acetylmorpholin-2-yl)methylamino]-3-nitrophenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1N(C(=O)C)CCOC1CNC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O AWQBEZQZXIAGFK-UHFFFAOYSA-N 0.000 claims 1
- KWHHZWYNCFXJQW-UUWRZZSWSA-N n-[4-[[(3r)-1-acetylpyrrolidin-3-yl]amino]-3-nitrophenyl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1N(C(=O)C)CC[C@H]1NC1=CC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1[N+]([O-])=O KWHHZWYNCFXJQW-UUWRZZSWSA-N 0.000 claims 1
- AZHPLHNIJVULGG-UHFFFAOYSA-N n-[5-bromo-6-(1,4-dioxan-2-ylmethoxy)pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Br)=CN=C1OCC1COCCO1 AZHPLHNIJVULGG-UHFFFAOYSA-N 0.000 claims 1
- UPMGBEHMGMQOBT-UHFFFAOYSA-N n-[5-bromo-6-[(1-methylpiperidin-4-yl)methoxy]pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CN(C)CCC1COC1=NC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1Br UPMGBEHMGMQOBT-UHFFFAOYSA-N 0.000 claims 1
- SUXRJZQNKLFVRB-UHFFFAOYSA-N n-[5-bromo-6-[(4-ethylmorpholin-3-yl)methoxy]pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound CCN1CCOCC1COC1=NC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1Br SUXRJZQNKLFVRB-UHFFFAOYSA-N 0.000 claims 1
- BZPZAQWGHAYPQB-UHFFFAOYSA-N n-[5-chloro-6-(2-methoxyethoxy)pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1=C(Cl)C(OCCOC)=NC=C1S(=O)(=O)NC(=O)C1=CC=C(N2CCN(CC=3CCC(C)(C)CC=3C=3C=CC(Cl)=CC=3)CC2)C=C1OC1=CN=C(NC=C2)C2=C1 BZPZAQWGHAYPQB-UHFFFAOYSA-N 0.000 claims 1
- CPETXTUMYSFBBH-UHFFFAOYSA-N n-[5-chloro-6-(oxan-4-ylmethoxy)pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CN=C1OCC1CCOCC1 CPETXTUMYSFBBH-UHFFFAOYSA-N 0.000 claims 1
- BFGCVKAZAMXHIQ-UHFFFAOYSA-N n-[5-chloro-6-[(4,4-difluorocyclohexyl)methoxy]pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CN=C1OCC1CCC(F)(F)CC1 BFGCVKAZAMXHIQ-UHFFFAOYSA-N 0.000 claims 1
- GCHGWBYYMDDACZ-UHFFFAOYSA-N n-[5-chloro-6-[(4-hydroxy-4-methylcyclohexyl)methoxy]pyridin-3-yl]sulfonyl-4-[4-[[7-(4-chlorophenyl)spiro[2.5]oct-6-en-6-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C1CC(C)(O)CCC1COC1=NC=C(S(=O)(=O)NC(=O)C=2C(=CC(=CC=2)N2CCN(CC=3CCC4(CC4)CC=3C=3C=CC(Cl)=CC=3)CC2)OC=2C=C3C=CNC3=NC=2)C=C1Cl GCHGWBYYMDDACZ-UHFFFAOYSA-N 0.000 claims 1
- KTYDJXQVTRGLLH-UHFFFAOYSA-N n-[5-chloro-6-[2-(oxolan-2-yl)ethoxy]pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1Cl)=CN=C1OCCC1CCCO1 KTYDJXQVTRGLLH-UHFFFAOYSA-N 0.000 claims 1
- BESVQSQTRRTQCW-JTXHSZDZSA-N n-[5-chloro-6-[[(1r,2r,4r,5r)-2-hydroxy-2-methyl-5-bicyclo[2.2.1]heptanyl]methoxy]pyridin-3-yl]sulfonyl-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Chemical compound C([C@@H]1C[C@H]2C[C@@H]1C[C@]2(O)C)OC(C(=C1)Cl)=NC=C1S(=O)(=O)NC(=O)C(C(=C1)OC=2C=C3C=CNC3=NC=2)=CC=C1N(CC1)CCN1CC(CCC(C)(C)C1)=C1C1=CC=C(Cl)C=C1 BESVQSQTRRTQCW-JTXHSZDZSA-N 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
Claims (9)
1.Jedinjenje koje ima Formulu (II)aili njegova terapeutski prihvatljiva so, pri čemu R100 je R57A, R57, OR57, SR57, S(O)R57, SO2R57, C(O)R57, CO(O)R57, OC(O)R57, OC(O)OR57, NH2, NHR57, N(R57)2, NHC(O)R57, NR57C(O)R57, NHS(O)2R57, NR57(O)2R57, NHC(O)OR57, NR57C(O)OR57, NHC(O)NH2, NHC(O)NHR57, NHC(O)N(R57)2, NR57C(O)NHR57, NR57C(O)N(R57)2, C(O)NH2, C(O)NHR57, C(O)N(R57)2, C(O)NHOH, C(O)NHOR57, C(O)NHSO2R57, C(O)NR57SO2R57, SO2NH2, SO2NHR57, SO2N(R57)2, C(O)H, C(O)OH, C(N)NH2, C(N)NHR57, C(N)N(R57)2, CNOH, CNOCH3, OH, (O), CN, N3, NO2, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl, Br iliI;n je 0, 1, 2, ili 3;A1 je N ili C(A2);A2 je H, R1, OR1, SR1, S(O)R1, SO2R1, C(O)R1, C(O)OR1, OC(O)R1, NHR1, N(R1)2, C(O)NHR1, C(O)N(R1)2, NHC(O)R1, NR1C(O)R1, NHC(O)OR1, NR1C(O)OR1, NHC(O)NH2, NHC(O)NHR1, NHC(O)N(R1)2, NR1C(O)NHR1, NR1C(O)N(R1)2, SO2NH2, SO2NHR1, SO2N(R1)2, NHSO2R1, NR1SO2R1, NHSO2NHR1, NHSO2N(R1)2, NR1SO2NHR1, NR1SO2N(R1)2, C(O)NHNOH, C(O)NHNOR1, C(O)NHSO2R1, C(NH)NH2, C(NH)NHR1, C(NH)N(R1)2, NHSO2NHR1, NHSO2N(CH3)R1, N(CH3)SO2N(CH3)R1, F, Cl, Br, I, CN, NO2, N3, OH, C(O)H, CHNOH, CH(NOCH3), CF3, C(O)OH, C(O)NH2 ili C(O)OR1A;B1 je H, R1, OR1, SR1, S(O)R1, SO2R1, C(O)R1, C(O)OR1, OC(O)R1, NMR1, N(R1)2, C(O)NHR1, C(O)N(R1)2, NHC(O)R1, NR1C(O)R1, NHC(O)OR1, NR1C(O)OR1, NHC(O)NH2, NHC(O)NHR1, NHC(O)N(R1)2, NR1C(O)NHR1, NR1C(O)N(R1)2, SO2NH2, SO2NHR1, SO2N(R1)2, NHSO2R1, NR1SO2R1, NHSO2NHR1, NHSO2N(R1)2, NR1SO2NHR1, NR1SO2N(R1)2, C(O)NHNOH, C(O)NHNOR1, C(O)NHSO2R1, C(NH)NH2, C(NH)NHR1, C(NH)N(R1)2, NHSO2NHR1, NHSO2N(CH3)R1, N(CH3)SO2N(CH3)R1, F, Cl, Br, I, CN, NO2, N3, OH, C(O)H, CHNOH, CH(NOCH3), CF3, C(O)OH, C(O)NH2 ili C(O)OR1A;D1 je H, R1, OR1, SR1, S(O)R1, SO2R1, C(O)R1, C(O)OR1, OC(O)R1, NHR1, N(R1)2, C(O)NHR1, C(O)N(R1)2, NHC(O)R1, NR1C(O)R1, NHC(O)OR1, NR1C(O)OR1, NHC(O)NH2, NHC(O)NHR1, NHC(O)N(R1)2, NR1C(O)NHR1, NR1C(O)N(R1)2, SO2NH2, SO2NHR1, SO2N(R1)2, NHSO2R1, NR1SO2R1, NHSO2NHR1, NHSO2N(R1)2, NR1SO2NHR1, NR1SO2N(R1)2, C(O)NHNOH, C(O)NHNOR1, C(O)NHSO2R1, C(NH)NH2, C(NH)NHR1, C(NH)N(R1)2 NHSO2NHR1, NHSO2N(CH3)R1, N(CH3)SO2N(CH3)R1, F, Cl, Br, I, CN, NO2, N3, OH, C(O)H, CHNOH, CH(NOCH3), CF3, C(O)OH, C(O)NH2 ili C(O)OR1A;E1 je H, R1, OR1, SR1, S(O)R1, SO2R1, C(O)R1, C(O)OR1, OC(O)R1, NHR1, N(R1)2, C(O)NHR1, C(O)N(R1)2, NHC(O)R1, NR1C(O)R1, NHC(O)OR1, NR1C(O)OR1, NHC(O)NH2, NHC(O)NHR1, NHC(O)N(R1)2, NR1C(O)NHR1, NR1C(O)N(R1)2, SO2NH2, SO2NHR1, SO2N(R1)2, NHSO2R1, NR1SO2R1, NHSO2NHR1, NHSO2N(R1)2, NR1SO2NHR1, NR1SO2N(R1)2, C(O)NHNOH, C(O)NHNOR1, C(O)NHSO2R1, C(NH)NH2, C(NH)NHR1, C(NH)N(R1)2 NHSO2NHR1, NHSO2N(CH3)R1, N(CH3)SO2N(CH3)R1, F, Cl, Br, I, CN, NO2, N3, OH, C(O)H, CHNOH, CH(NOCH3), CF3, C(O)OH, C(O)NH2 ili C(O)OR1A; iY1 je H, CN, NO2, C(O)OH, F, Cl, Br, I, CF3, OCF3, CF2CF3, OCF2CF3, R17, OR17, C(O)R17, C(O)OR17, SR17, SO2R17, NH2, NHR17, N(R17)2, NHC(O)R17, C(O)NH2, C(O)NHR17, C(O)N(R17)2, NHS(O)R17 ili NHSO2R17; iliE1 i Y1, zajedno sa atomima za koji su vezani, su benzen, naftilen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken; iA2, B1, i D1 su nezavisno odabrani H, R1, OR1, SR1, S(O)R1, SO2R1, C(O)R1, C(O)OR1, OC(O)R1, NHR1, N(R1)2, C(O)NHR1, C(O)N(R1)2, NHC(O)R1, NR1C(O)R1, NHC(O)OR1, NR1C(O)OR1, NHC(O)NH2, NHC(O)NHR1, NHC(O)N(R1)2, NR1C(O)NHR1, NR1C(O)N(R1)2, SO2NH2, SO2NHR1, SO2N(R1)2, NHSO2R1, NR1SO2R1, NHSO2NHR1, NHSO2N(R1)2, NR1SO2NHR1, NR1SO2N(R1)2, C(O)NHNOH, C(O)NHNOR1, C(O)NHSO2R1, C(NH)NH2, C(NH)NHR1, C(NH)N(R1)2, NHSO2NHR1, NHSO2N(CH3)R1, N(CH3)SO2N(CH3)R1, F, Cl, Br, I, CN, NO2, N3, OH, C(O)H, CHNOH, CH(NOCH3), CF3, C(O)OH, C(O)NH2 ili C(O)OR1A; iliY1 i B1, zajedno sa atomima za koji su vezani, su benzen, naftilen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken; iA2, D1, i E1 su nezavisno odabrani H, R1, OR1, SR1, S(O)R1, SO2R1, C(O)R1, C(O)OR1, OC(O)R1, NHR1, N(R1)2, C(O)NHR1, C(O)N(R1)2, NHC(O)R1, NR1C(O)R1, NHC(O)OR1, NR1C(O)OR1, NHC(O)NH2, NHC(O)NHR1, NHC(O)N(R1)2, NR1C(O)NHR1, NR1C(O)N(R1)2, SO2NH2, SO2NHR1, SO2N(R1)2, NHSO2R1, NR1SO2R1, NHSO2NHR1, NHSO2N(R1)2, NR1SO2NHR1, NR1SO2N(R1)2, C(O)NHNOH, C(O)NHNOR1, C(O)NHSO2R1, C(NH)NH2, C(NH)NHR1, C(NH)N(R1)2 NHSO2NHR1, NHSO2N(CH3)R1, N(CH3)SO2N(CH3)R1, F, Cl, Br, I, CN, NO2, N3, OH, C(O)H, CHNOH, CH(NOCH3), CF3, C(O)OH, C(O)NH2 ili C(O)OR1A; iliA2 i B1, zajedno sa atomima za koji su vezani, su benzen, naftilen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken; iD1, E1, i Y1 su nezavisno odabrani H, R1, OR1, SR1, S(O)R1, SO2R1, C(O)R1, C(O)OR1, OC(O)R1, NHR1, N(R1)2, C(O)NHR1, C(O)N(R1)2, NHC(O)R1, NR1C(O)R1, NHC(O)OR1, NR1C(O)OR1, NHC(O)NH2, NHC(O)NHR1, NHC(O)N(R1)2, NR1C(O)NHR1, NR1C(O)N(R1)2, SO2NH2, SO2NHR1, SO2N(R1)2, NHSO2R1, NR1SO2R1, NHSO2NHR1, NHSO2N(R1)2, NR1SO2NHR1, NR1SO2N(R1)2, C(O)NHNOH, C(O)NHNOR1, C(O)NHSO2R1, C(NH)NH2, C(NH)NHR1, C(NH)N(R1)2 NHSO2NHR1, NHSO2N(CH3)R1, N(CH3)SO2N(CH3)R1, F, Cl, Br, I, CN, NO2, N3, OH, C(O)H, CHNOH, CH(NOCH3), CF3, C(O)OH, C(O)NH2 ili C(O)OR1A; iliA2 i D1, zajedno sa atomima za koji su vezani, su benzen, naftalen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken; iB1, E1, i Y1 su nezavisno odabrani H, R1, OR1, SR1, S(O)R1, SO2R1, C(O)R1, C(O)OR1, OCCCOR1, NHR1, N(R1)2, C(O)NHR1, C(O)N(R1)2, NHC(O)R1, NR1C(O)R1, NHC(O)OR1, NR1C(O)OR1, NHC(O)NH2, NHC(O)NHR1, NHC(O)N(R1)2, NR1C(O)NHR1, NR1C(O)N(R1)2, SO2NH2, SO2NHR1, SO2N(R1)2, NHSO2R1, NR1SO2R1, NHSO2NHR1, NHSO2N(R1)2, NR1SO2NHR1, NR1SO2N(R1)2, C(O)NHNOH, C(O)NHNOR1, C(O)NHSO2R1, C(NH)NH2, C(NH)NHR1, C(NH)N(R1)2 NHSO2NHR1, NHSO2N(CH3)R1, N(CH3)SO2N(CH3)R1, F, Cl, Br, I, CN, NO2, N3, OH, C(O)H, CHNOH, CH(NOCH3), CF3, C(O)OH, C(O)NH2 ili C(O)OR1A;R1 je R2, R3, R4 ili R5;R1A je cikloalkil, cikloalkenil ili cikloalkinil;R2 je fenil, koji nije spojen ili je spojen sa R2A; R2A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R3 je heteroaril, koji nije spojen ili je spojen sa R3A; R3A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R4 je cikloalkil, cikloalkenil, heterocikloalkil ili heterocikloalkenil, od kojih svaki nije spojen ili je spojen sa R4A; R4A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken; R5 je alkil, alkenil ili alkinil, od kojih je svaki nesupstituisan ili susptituisan sa jednim ili dva ili tri supstituenta nezavisno odabrani između R6, NC(R6A)(R6B), R7, OR7, SR7, S(O)R7, SO2R7, NHR7, N(R7)2, C(O)R7, C(O)NH2, C(O)NHR7, C(O)N(R7)2, NHC(O)R7, NR7C(O)R7, NHSO2R7, NHC(O)OR7, SO2NH2, SO2NHR7, SO2N(R7)2, NHC(O)NH2, NHC(O)NHR7, NHC(O)CH(CH3)NHC(O)CH(CH3)NH2, NHC(O)CH(CH3)NHC(O)CH(CH3)NHR7, OH, (O), C(O)OH, N3, CN, NH2, CF3, CF2CF3, F, Cl, Br i I;R6 je C2-C5-spiroalkil, od kojih je svaki nesupstituisan ili supstituisan sa OH, (O), N3, CN, CF3, CF2CF3, F, Cl, Br, I, NH2, NH(CH3) ili N(CH3)2;R6A i R6B su nezavisno odabrani alkil;R7 je R8, R9, R10 ili R11;R8 je fenil, koji nije spojen ili je spojen sa R8A; R8A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R9 je heteroaril, koji nije spojen ili je spojen sa R9A; R9A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R10 je cikloalkil, cikloalkenil, heterocikloalkil ili heterocikloalkenil, od kojih svaki nije spojen ili je spojen sa R10A; R10A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R11 je alkil, alkenil ili alkinil, od kojih je svaki nesupstituisan ili supstituisan sa jednim ili dva ili tri supstituensa nezavisno odabrani između R12, OR12, SR12, S(O)R12, SO2R12, C(O)R12, CO(O)R12, OC(O)R12, OC(O)OR12, NH2, NHR12, N(R12)2, NHC(O)R12, NR12C(O)R12, NHS(O)2R12, NR12S(O)2R12, NHC(O)OR12, NR12C(O)OR12, NHC(O)NH2, NHC(O)NHR12, NHC(O)N(R12)2, NR12C(O)NHR12, NR12C(O)N(R12)2, C(O)NH2, C(O)NHR12, C(O)N(R12)2, C(O)NHOH, C(O)NHOR12, C(O)NHSO2R12, C(O)NR12SO2R12, SO2NH2, SO2NHR12, SO2N(R12)2, C(O)H, C(O)OH, C(N)NH2, C(N)NHR12, C(N)N(R12)2, CNOH, CNOCH3, OH, (O), CN, N3, NO2, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl, Br i I;R12 je R13, R14, R15 ili R16;R13 je fenil, koji nije spojen ili je spojen sa R13A; R13A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R14 je heteroaril, koji nije spojen ili je spojen sa R14A; R14A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R15 je cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken, od kojih svaki nije spojen ili je spojen sa R15A; R15A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkane ili heterocikloalken;R16 je alkil, alkenil ili alkinil;R17 je R18, R19, R20 ili R21;R18 je fenil, koji nije spojen ili je spojen sa R18A; R18A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R19 je heteroaril, koji nije spojen ili je spojen sa R19A; R19A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R20 je cikloalkil, cikloalkenil, heterocikloalkil ili heterocikloalkenil od kojih svaki nije spojen ili je spojen sa R20A; R20A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R21 je alkil, alkenil ili alkinil, od kojih je svaki nesupsituisan ili supstituisan sa jednim ili dva ili tri supstituenta nezavisno odabrani između R22, OR22, SR22, S(O)R22, SO2R22, C(O)R22, CO(O)R22, OC(O)R22, OC(O)OR22, NH2, NHR22, N(R22)2, NHC(O)R22, NR22C(O)R22, NHS(O)2R22, NR22S(O)2R22, NHC(O)OR22, NR22C(O)OR22, NHC(O)NH2, NHC(O)NHR22, NHC(O)N(R22)2, NR22C(O)NHR22, NR22C(O)N(R22)2, C(O)NH2, C(O)NHR22,C(O)N(R22)2, C(O)NHOH, C(O)NHOR22, C(O)NHSO2R22, C(O)NR22SO2R22, SO2NH2, SO2NHR22, SO2N(R22)2, C(O)H, C(O)OH, C(N)NH2, C(N)NHR22, C(N)N(R22)2, CNOH, CNOCH3, OH, (O), CN, N3, NO2, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl, Br i I;R22 je R23, R24 ili R25;R23 je fenil, koji nije spojen ili je spojen sa R23A; R23A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R24 je heteroaren, koji nije spojen ili je spojen sa R24A; R24A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R25 je cikloalkil, cikloalkenil, heterocikloalkil ili heterocikloalkenil, od kojih svaki nije spojen ili je spojen sa R25A; R25A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;Z2 je R28, R29 je R30;L1 je R37, OR37, SR37, S(O)R37, SO2R37, C(O)R37, CO(O)R37, OC(O)R37, OC(O)OR37, NHR37, C(O)NH, C(O)NR37, C(O)NHOR37, C(O)NHSO2R37, SO2NH, SO2NHR37, C(N)NH ili C(N)NHR37;R28 je fenilen, koji nije spojen ili je spojen sa R28A; R28A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R29 je heteroarilen, koji nije spojen ili je spojen sa R29A; R29A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R30 je cikloalkilen, cikloalkenilen, heterocikloalkilen ili heterocikloalkenilen, od kojih svaki nije spojen ili je spojen sa R30A; R30A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R37 je veza ili R37A;R37A je alkilen, alkenilen, ili alkinilen, od kojih je svaki nesupstituisan ili supstituisan sa jednim ili dva ili tri supstituenta nezavisno odabrana između R37B, OR37B, SR37B, S(O)R37B, SO2R37B, C(O)R37B, CO(O)R37B, OC(O)R37B, OC(O)OR37B, NH2, NHR37B, N(R37B)2, NHC(O)R37B, NR37BC(O)R37B, NHS(O)2R37B, NR37BS(O)2R37B, NHC(O)OR37B, NR37BC(O)OR37B, NHC(O)NH2, NHC(O)NHR37B, NHC(O)N(R37B)2, NR37BC(O)NHR37B, NR37BC(O)N(R37B)2, C(O)NH2, C(O)NHR37B, C(O)N(R37B)2, C(O)NHOH, C(O)NHOR37B, C(O)NHSO2R37B, C(O)NR37BSO2R37B, SO2NH2, SO2NHR37B, SO2N(R37B)2, C(O)H, C(O)OH, C(N)NH2, C(N)NHR37B, C(N)N(R37B)2, CNOH, CNOCH3, OH, (O), CN, N3, NO2, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl,Br i I;R37B je alkil, alkenil, alkinil, ili R37C;R37C je fenil, heteroaril, cikloalkil, cikloalkenil, heterocikloalkil, ili heterocikloalkenil;Z3 je R38, R39 ili R40;R38 je fenil, koji nije spojen ili je spojen sa R38A; R38A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R39 je heteroaril, koji nije spojen ili je spojen sa R39A; R39A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R40 je cikloalkil, cikloalkenil, heterocikloalkil ili heterocikloalkenil, od kojih svaki nije spojen ili je spojen sa R40A; R40A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;pri čemu ciklični ostaci prikazani sa E1 i Y1 zajedno, Y1 i B1 zajedno, A2 i B1 zajedno, A2 i D1 zajedno, R1A, R2, R2A, R3, R3A, R4, R4A, R6, R8, R8A, R9, R9A R10, R10A, R13, R13A, R14, R14A, R15, R15A, R18, R18A, R19, R19A, R20, R20A, R23, R23A, R24, R24A, R25, R25A, R28, R28A, R29, R29A, R30, R30A, R38, R38A, R39, R39A, R40 i R40A su nezavisno nesupstituisani, supstituisani ili dalje supstituisani sa jednim ili dva ili tri ili četiri supstituenta nezavisno odabrani između R57A, R57, OR57, SR57, S(O)R57, SO2R57, C(O)R57, CO(O)R57, OC(O)R57, OC(O)OR57, NH2, NHR57, N(R57)2, NHC(O)R57, NR57C(O)R57, NHS(O)2R57, NR57S(O)2R57, NHC(O)OR57, NR57C(O)OR57, NHC(O)NH2, NHC(O)NHR57, NHC(O)N(R57)2, NR57C(O)NHR57, NR57C(O)N(R57)2, C(O)NH2, C(O)NHR57, C(O)N(R57)2, C(O)NHOH, C(O)NHOR57, C(O)NHSO2R57, C(O)NR57SO2R57, SO2NH2, SO2NHR57, SO2N(R57)2, C(O)H, C(O)OH, C(N)NH2, C(N)NHR57, C(N)N(R57)2, CNOH, CNOCH3, OH, (O), CN, N3, NO2, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl, Br i I;R57A je spiroalkil ili heterospiroalkil;R57 je R58, R59, R60 ili R61;R58 je fenil, koji nije spojen ili je spojen sa R58A; R58A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R59 je heteroaril, koji nije spojen ili je spojen sa R59A; R59A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R60 je cikloalkil, cikloalkenil, heterocikloalkil ili heterocikloalkenil, od kojih svaki nije spojen ili je spojen sa R60A; R60A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R61 je alkil, alkenil ili alkinil, od kojih je svaki nesupstituisan ili supstituisan sa jednim ili dva ili tri supstituenta nezavisno odabrani između R62, OR62, SR62, S(O)R62, SO2R62, C(O)R62, CO(O)R62, OC(O)R62, OC(O)OR62, NH2, NHR62, N(R62)2, NHC(O)R62, NR62C(O)R62, NHS(O)2R62, NR62S(O)2R62, NHC(O)OR62, NR62C(O)OR62, NHC(O)NH2, NHC(O)NHR62, NHC(O)N(R62)2, NR62C(O)NHR62, NR62C(O)N(R62)2, C(O)NH2, C(O)NHR62, C(O)N(R62)2, C(O)NHOH, C(O)NHOR62, C(O)NHSO2R62, C(O)NR62SO2R62, SO2NH2, SO2NHR62, SO2N(R62)2, C(O)H, C(O)OH, C(N)NH2, C(N)NHR62, C(N)N(R62)2, CNOH, CNOCH3, OH, (O), CN, N3, NO2, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl, Br i I;R62 je R63, R64, R65 ili R66;R63 je fenil, koji nije spojen ili je spojen sa R63A; R63A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R64 je heteroaril, koji nije spojen ili je spojen sa R64A; R64A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R65 je cikloalkil, cikloalkenil, heterocikloalkil ili heterocikloalkenil, od kojih svaki nije spojen ili je spojen sa R65A; R65A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R66 je alkil, alkenil ili alkinil, od kojih je svaki nesupstituisan ili supstituisan sa jednim ili dva ili tri supstituenta nezavisno odabrani između R67, OR67, SR67, S(O)R67, SO2R67, C(O)R67, CO(O)R67, OC(O)R67, OC(O)OR67, NH2, NHR67, N(R67)2, NHC(O)R67, NR67C(O)R67, NHS(O)2R67, NR67S(O)2R67, NHC(O)OR67, NR67C(O)OR67, NHC(O)NH2, NHC(O)NHR67, NHC(O)N(R67)2, NR67C(O)NHR67, NR67C(O)N(R67)2, C(O)NH2, C(O)NHR67, C(O)N(R67)2, C(O)NHOH, C(O)NHOR67, C(O)NHSO2R67, C(O)NR67SO2R67, SO2NH2, SO2NHR67, SO2N(R67)2, C(O)H, C(O)OH, C(N)NH2, C(N)NHR67, C(N)N(R67)2, CNOH, CNOCH3, OH, (O), CN, N3, NO2, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl, Br i I;R67 je alkil, alkenil, alkinil, fenil, heteroaril, cikloalkil, cikloalkenil, heterocikloalkil ili heterocikloalkenil;pri čemu ciklični ostaci prikazani sa R57A, R58, R59, R60, R63, R64, R65, i R67 su nesupstituisani ili supstituisani sa jednim ili dva ili tri ili četiri supstituenta nezavisno odabrani između R68, OR68, SR68, S(O)R68, SO2R68, C(O)R68, CO(O)R68, OC(O)R68, OC(O)OR68, NH2, NHR68, N(R68)2, NHC(O)R68, NR68C(O)R68, NHS(O)2R68, NR68S(O)2R68, NHC(O)OR68, NR68C(O)OR68, NHC(O)NH2, NHC(O)NHR68, NHC(O)N(R68)2, NR68C(O)NHR68, NR68C(O)N(R68)2, C(O)NH2, C(O)NHR68, C(O)N(R68)2, C(O)NHOH, C(O)NHOR68, C(O)NHSO2R68, C(O)NR68SO2R68, SO2NH2, SO2NHR68, SO2N(R68)2, C(O)H, C(O)OH, C(N)NH2, C(N)NHR68, C(N)N(R68)2, CNOH, CNOCH3, OH, (O), CN, N3, NO2, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl, Br i I;R68 je R69, R70, R71 ili R72;R69 je fenil, koji nije spojen ili je spojen sa R69A; R69A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R70 je heteroaril, koji nije spojen ili je spojen sa R70A; R70A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R71 je cikloalkil, cikloalkenil, heterocikloalkil ili heterocikloalkenil, od kojih svaki nije spojen ili je spojen sa R71A; R71A je benzen, heteroaren, cikloalkan, cikloalken, heterocikloalkan ili heterocikloalken;R72 je alkil, alkenil ili alkinil, od kojih je svaki nesupstituisan ili supstituisan sa jednim ili dva ili tri supstituensa nezavisno odabran između R73, OR73, SR73, S(O)R73, SO2R73 C(O)R73, CO(O)R73, OC(O)R73, OC(O)OR73, NH2, NHR73, N(R73)2, NHC(O)R73, NR73C(O)R73, NHS(O)2R73, NR73S(O)2R73, NHC(O)OR73, NR73C(O)OR73, NHC(O)NH2, NHC(O)NHR73, NHC(O)N(R73)2, NR73C(O)NHR73, NR73C(O)N(R73)2, C(O)NH2, C(O)NHR73, C(O)N(R73)2, C(O)NHOH, C(O)NHOR73, C(O)NHSO2R73, C(O)NR73SO2R73, SO2NH2, SO2NHR73, SO2N(R73)2, C(O)H, C(O)OH, C(N)NH2, C(N)NHR73, C(N)N(R73)2, CNOH, CNOCH3, OH, (O), CN, N3, NO2, CF3, CF2CF3, OCF3, OCF2CF3, F, Cl, Br i I;R73 je alkil, alkenil ili alkinil, fenil, heteroaril, cikloalkil, cikloalkenil, heterocikloalkil ili heterocikloalkenil; ipri čemu ostaci prikazani sa R69, R70, i R71 su nesupstituisani ili supstituisani sa jednim ili dva ili tri ili četiri supstituensa nezavisno odabrani između NH2, C(O)NH2, C(O)NHOH, SO2NH2, CF3, CF2CF3, C(O)H, C(O)OH, C(N)NH2, OH, (O), CN, N3, NO2, OCF3, OCF2CF3, F, Cl, Br i I.
2. Jedinjenje ili terapeutski prihvatljiva so prema zahtevu 1, gde n je 0; A1 je N ili C(A2); A2 je H, F, Br, I, ili Cl; B1 je R1, OR1, NHR1, NHC(O)R1, F, Br, I ili Cl; D1 je H, F, Br, I, ili Cl; E1 je H; i Y1 je H, CN, NO2, F, Cl, Br, I, CF3, R17, OR17, SR17, SO2R17, ili C(O)NH2; ili Y1 i B1, zajedno sa atomima za koji su vezani, su benzen, heteroaren, ili heterocikloalken; i A2, D1, i E1 su svaki H; R1 je R4 ili R5; R4 je cikloalkil ili heterocikloalkil; R5 je alkil ili alkinil, od kojih je svaki nesupstituisan ili supstituisan sa jednim ili dva ili tri nezavisno odabranim R7, OR7, NHR7, N(R7)2, CN, OH, F, Cl, Br ili I; R7 je R8, R9, R10 ili R11; R8 je fenil; R9 je heteroaril; R10 je cikloalkil, cikloalkenil, ili heterocikloalkil; od kojih svaki nije spojen ili je spojen sa R10A; R10A je heteroaren; R11 je alkil, koji je nesupstituisan ili supstituisan sa jednim ili dva ili tri nezavisno odabranim R12, OR12 ili CF3; R12 je R14 ili R16; R14 je heteroaril; R16 je alkil; R17 je R21; R21 je alkil ili alkinil, od kojih je svaki nesupstituisan ili supstituisan sa jednim ili dva ili tri nezavisno odabranim R22, F, Cl, Br ili I; R22 je R25; R25 je heterocikloalkil; Z2 je R30; L1 je R37; R30 je heterocikloalkilen; R37 je R37A; R37A je alkilen; Z3 je R38, ili R40 R38 je fenil; R40 je cikloalkil, cikloalkenil, ili heterocikloalkenil; pri čemu ciklični ostaci prikazani sa Y1 i B1 zajedno, R4, R8, R10, R25, R30, R38, i R40 su nezavisno nesupstituisani, supstituisani ili dalje supstituisani sa jednim ili dva ili tri ili četiri ili pet supstituenata nezavisno odabrani između R57A, R57, OR57, SO2R57, C(O)R57, CO(O)R57, C(O)N(R57)2, NH2, NHR57, N(R57)2, NHC(O)R57, NHS(O)2R57, OH, CN, (O), F, Cl, Br i I; R57A je spiroalkil, ili spiroheteroalkil; R57 je R58, R60 ili R61; R58 je fenil; R60 je cikloalkil ili heterocikloalkil; R61 je alkil koji je nesupstituisan ili supstituisan sa jednim ili dva ili tri supstituenta nezavisno odabrana između R62, OR62, N(R62)2, C(O)OH, CN, F, Cl, Br i I; R62 je R65 ili R66; R65 je cikloalkil ili heterocikloalkil; R66 je alkil, koji je nesupstituisan ili supstituisan sa OR67; R67 je alkil; pri čemu ciklični ostaci prikazani sa R57A, R58, i R60 su nesupstituisani ili supstituisani sa jednim ili dva ili tri ili četiri supstituenta nezavisno odabrani između R68, F, Cl, Br i I; R68 je R71 ili R72; R71 je heterocikloalkil; i R72 je alkil, koji je nesupstituisan ili supstituisan sa jednim ili dva F.
3. Jedinjenje ili terapeutski prihvatljiva so prema zahtevu 1, gde jedinjenje ima formulu (III) gde n, p, r, i q su svaki 0, a R100, R101, R102 i R103 su svaki odsutni; A1 je N ili C(A2); A2 je H, F, Br, I, ili Cl; B1 je R1, OR1, NHR1, NHC(O)R1, F, Br, I ili Cl; D1 je H, F, Br, I, ili Cl; E1 je H; i Y1 je H, CN, NO2, F, Cl, Br, I, CF3, R17, OR17, SR17, SO2R17, ili C(O)NH2; ili Y1 i B1, zajedno sa atomima za koji su vezani, su benzen, heteroaren, ili heterocikloalken; i A2, D1, i E1 su svaki H; R1 je R4 ili R5; R4 je cikloalkil ili heterocikloalkil; R5 je alkil ili alkinil, od kojih je svaki nesupstituisan ili supstituisan sa jednim ili dva ili tri supstituenta nezavisno odabrani između R7, OR7, NHR7, N(R7)2, CN, OH, F, Cl, Br i I; R8 je fenil; R9 je heteroaril; R10 je cikloalkil, cikloalkenil, ili heterocikloalkil; od kojih svaki nije spojen ili je spojen sa R10A; R10A je heteroaren; R11 je alkil, koji je nesupstituisan ili supstituisan sa jednim ili dva ili tri supstituensa nezavisno odabrani između R12, OR12 i CF3; R12 je R14 ili R16; R14 je heteroaril; R16 je alkil; R17 je R21; R21 je alkil ili alkinil, od kojih je svaki nesupstutisan ili supstituisan sa jednim ili dva ili tri supstituensa nezavisno odabrani između R22, F, Cl, Br i I; R22 je R25; R25 je heterocikloalkil; pri čemu ciklični ostaci prikazani sa Y1 i B1 zajedno, R4, R8, R10, i R25, su nezavisno nesupstituisani, supstituisani ili dalje supstituisani sa jednim ili dva ili tri ili četiri ili pet supstituenata nezavisno odabrani između R57A, R57, OR57, SO2R57, C(O)R57, CO(O)R57, C(O)N(R57)2, NH2, NHR57, N(R57)2, NHC(O)R57, NHS(O)2R57, OH, CN, (O), F, Cl, Br i I; R57A je spiroalkil ili spiroheteroalkil; R57 je R58, R60 ili R61; R58 je fenil; R60 je cikloalkil ili heterocikloalkil; R61 je alkil, koji je nesupstituisan ili supstituisan sa jednim ili dva ili tri supstituisan nezavisno odabranim između R62, OR62, N(R62)2, C(O)OH, CN, F, Cl, Br i I; R62 je R65 ili R66; R65 je cikloalkil ili heterocikloalkil; R66 je alkil, koji je nesupstituisan ili supstituisan sa OR67; R67 je alkil; pri čemu ciklični ostaci prikazani sa R57A, R58, i R60 su nesupstituisani ili supstituisani sa jednim ili dva ili tri ili četiri supstituenta nezavisno odabrani između R68, F, Cl, Br i I; R68 je R71 ili R72; R71 je heterocikloalkil; i R72 je alkil, koji je nesupstituisan ili supstituisan sa jednim ili dva F.
4. Jedinjenje ili terapeutska so prema zahtevu 1, koje je: 4- {4-[(4’-hloro-1,1’-bifenil-2-il) metil] piperazin-1-il}-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4- {4-[(4’-hloro-1,1’-bifenil-2-il) metil] piperazin-1-il}-N-({4-[(3-morfolin-4-ilpropil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4- {[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(1-tetrahidro-2H-piran-4-ilpiperidin-4-il) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1-metil piperidin-4-il) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-metil piperazin-1-il) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-morfolin-4-ilcikloheksil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(2-metoksi etil) amino]-3-nitrofenil}sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(3S)-tetrahidro-2H-piran-3-ilmetil] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-(1,4-dioksan-2-ilmetoksi)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(3R)-tetrahidro-2H-piran-3-ilmetil] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-(2-naftilsulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(2-metoksi etil) amino]-3-[(trifluorometil) sulfonil] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b] piridin-5-iloksi)-N-({4-[(tetrahidro-2H-piran-4-ilmetil) amino]-3-[(trifluorometil) sulfonil] fenil} sulfonil) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[3-nitro-4-(tetra hidro-2H-piran-4-ilmetoksi) fenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1,4-dioksan-2-ilmetil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(2,2,2-trifluoroetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(3,3,3-trifluoropropil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(2S)-1,4-dioksan-2-ilmetoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Cis-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(4-metoksicikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(2R)-1,4-dioksan-2-ilmetoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-N-({4-[(1,4-dioksan-2-ilmetil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-N-{[4-(1,4-dioksan-2-ilmetoksi)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil{piperazin-1-il)-N-({4-[(4-morfolin-4-ilcikloheksil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(4-metoksicikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-N-{[5-cijano-6-(tetrahidro-2H-piran-4-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[5-cijano-6-(tetra hidro-2H-piran-4-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-fluorotetra hidro-2H-piran-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-{[3-(aminokarbonil)-4-(tetrahidro-2H-piran-4-ilmetoksi) fenil] sulfonil}-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Cis-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-morfolin-4-ilcikloheksil) amino]-3-nitrofenil}sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[5-hloro-6-(tetra hidro-2H-piran-4-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-N-{[5-hloro-6-(tetrahidro-2H-piran-4-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi)-N-{[4-[(tetrahidro-2H-piran-4-ilmetil) amino]-3-(trifluorometil) fenil] sulfonil} benzamid; 4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi)-N-({4-[(tetrahidro-2H-piran-4-ilmetil) amino]-3-[(trifluorometil) sulfonil] fenil} sulfonil) benzamid; Trans-4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-N-({4-[(4-morfolin-4-ilcikloheksil) amino]-3-[(trifluorometil) sulfonil] fenil} sulfonil)-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-N-({4-[(1-metil piperidin-4-il) amino]-3-[(trifluorometil) sulfonil] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 5-({[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzoil] amino} sulfonil)-2-(tetrahidro-2H-piran-4-ilmetoksi) nikotinamid; N-({5-bromo-6-[(1-metilpiperidin-4-il) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1-metil piperidin-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[5-cijano-6-(1,4-dioksan-2-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-{[5-bromo-6-(1,4-dioksan-2-ilmetoksi) piridin-3-il] sulfonil}-4-(4-{[2-(4-hlorofenil)-4,4-dimetil cikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(2,2-dimetil tetrahidro-2H-piran-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({3-hloro-5-cijano-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({4-[(1-acetilpiperidin-4-il) amino]-3-nitrofenil} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({2-hloro-5-fluoro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(3-morfolin-4-ilpropil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({5-cijano-6-[(4-fluorotetrahidro-2H-piran-4-il) metoksi] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[5-cijano-6-(2-morfolin-4-iletoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(3-hloro-4-{[2-(2-metoksietoksi) etil] sulfonil} fenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-di metilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[2-(2-metoksietoksi) etil] sulfonil}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-morfolin-4-ilcikloheksil) oksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-bromo-6-[(1-tetrahidro-2H-piran-4-ilpiperidin-4-il) amino] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(2-cijanoetil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Cis-4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-N-({4-[(4-morfolin-4-ilcikloheksil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-N-{[4-({4-[bis(ciklopropilmetil) amino] cikloheksil} amino)-3-nitrofenil] sulfonil}-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(1-metil piperidin-4-il) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(morfolin-3-ilmetil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-N-({4-[(4-metil piperazin-1-il) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-morfolin-4-ilbut-2-inil) oksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[5-etinil-6-(tetra hidro-2H-piran-4-ilmetoksi) piridin-3-il] sufonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-okso-3,4-di hidrohinazolin-6-il) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[8-(4-hlorofenil) spiro[4.5]dec-7-en-7-il] metil} piperazin-1-il)-N-({4-[(4-morfolin-4-il cikloheksil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Cis-4-(4-{[4-(4-hlorofenil)-6,6-dimetil-5,6-dihidro-2H-piran-3-il] metil} piperazin-1-il)-N-[(4-{[(4-metoksicikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[8-(4-hlorofenil) spiro[4.5]dec-7-en-7-il] metil} piperazin-1-il)-N-({4-[(4-fluorotetrahidro-2H-piran-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[8-(4-hlorofenil) spiro[4.5]dec-7-en-7-il] metil} piperazin-1-il)-N-[(4-{[(4-metoksi cikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-5,5-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetra hidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-5,5-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[5-cijano-6-(tetra hidro-2H-piran-4-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; terc-butil 3- {[4-({[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzoil] amino} sulfonil)-2-nitrofenoksi] metil} morfolin-4-karboksilat; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-(morfolin-3-ilmetoksi)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[8-(4-hlorofenil) spiro[4.5]dec-7-en-7-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[1-(metil sulfonil) piperidin-4-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1,1-dioksido tetrahidro-2H-tiopiran-4-il) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(4-hloro-3-nitrofenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[1-(2,2,2-trifluoroetil) piperidin-4-il] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({5-cijano-6-[(1-tetrahidro-2H-piran-4-ilpiperidin-4-il) oksi] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[5-izopropil-6-(tetrahidro-2H-piran-4-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({3-hloro-5-fluoro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({1-[2-fluoro-1-(fluorometil) etil] piperidin-4-il} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(4-fluorotetrahidro-2H-piran-4-il) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[1-(2,2-di fluoroetil) piperidin-4-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1-ciklopropil piperidin-4-il) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(1-morfolin-4-ilcikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[4-(diciklo propilamino) cikloheksil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-6,6-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetra hidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-bromo-6-[(4-etilmorfolin-3-il) metoksi] piridin-3-il}sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-etil morfolin-3-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(4-tetrahidro-2H-piran-4-ilmorfolin-3-il) metoksi] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(3S)-1-tetrahidro-2H-piran-4-ilpiperidin-3-il] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({5-cijano-6-[(tetra hidro-2H-piran-4-ilmetil) amino] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1,1-dioksido tiomorfolin-4-il) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(4-{[(4-aminotetrahidro-2H-piran-4-il) metil] amino{-3-nitrofenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({5-cijano-6-[(4-morfolin-4-ilcikloheksil) amino] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-cijano-4-[(tetra hidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-[(1S,3R)-3-morfolin-4-ilciklopentil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(1R,3S)-3-morfolin-4-ilciklopentil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(morfolin-2-ilmetil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetra hidrofuran-3-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({1-[cis-3-fluorotetrahidro-2H-piran-4-il] piperidin-4-il} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(1-tetrahidro-2H-piran-4-ilazetidin-3-il) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(1-tetrahidrofuran-3-ilazetidin-3-il) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[3-nitro-4-({[(3R)-1-tetrahidro-2H-piran-4-ilpirolidin-3-il] metil} amino) fenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-5,5-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-fluorotetra hidro-2H-piran-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 2-(1H-pirolo[2,3-b]piridin-5-iloksi)-4-(4-((2-(4-hlorofenil)-4,4-dimetilcikloheks-1-enil) metil) piperazin-1-il)-N-(4-((trans-4-hidroksicikloheksil) metoksi)-3-nitrofenilsulfonil) benzamid; 2-(1H-pirolo[2,3-b]piridin-5-iloksi)-4-(4-((2-(4-hlorofenil)-4,4-dimetilcikloheks-1-enil) metil) piperazin-1-il)-N-(4-((cis-4-metoksicikloheksil) metoksi)-3-nitrofenilsulfonil) benzamid; Cis-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[4-(ciklo propilamino) cikloheksil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[4-(tetrahidro-2H-piran-4-ilamino) cikloheksil] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-N-({5-bromo-6-[(4-morfolin-4-ilcikloheksil) oksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-metoksi cikloheksil) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; terc-butil 4-{[4-({[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzoil] amino} sulfonil)-2-nitrofenoksi] metil}-4-fluoro piperidin-1-karboksilat; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-fluoro piperidin-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[4-(4-tetrahidro-2H-piran-4-ilpiperazin-1-il) cikloheksil] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({1-[2-fluoro-1-(fluorometil) etil] piperidin-4-il} metoksi)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(3R)-1-tetrahidro-2H-piran-4-ilpirolidin-3-il] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3R)-1-(2,2-di metiltetrahidro-2H-piran-4-il) pirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(3S)-1-tetrahidro-2H-piran-4-ilpirolidin-3-il] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3S)-1-(2,2-dimetiltetrahidro-2H-piran-4-il) pirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(4-metil morfolin-2-il) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[4-(2-metoksi etil) morfolin-2-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(4-{[(4-acetilmorfolin-2-il) metil] amino}-3-nitrofenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-di metilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[trans-4-(fluoro metil)-1-oksetan-3-ilpirolidin-3-il] metoksi}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(4-fluorotetra hidro-2H-piran-4-il) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(1-oksetan-3-ilpiperidin-4-il) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1-ciklobutil piperidin-4-il) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[1-(2,2-dimetil tetrahidro-2H-piran-4-il) piperidin-4-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3S)-1-ciklo propilpirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(1-tetrahidrofuran-3-ilpiperidin-4-il) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3R)-1-ciklo propilpirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[3-nitro-4-({[(3S)-1-tetrahidro-2H-piran-4-ilpirolidin-3-il] metil} amino) fenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(3-hidroksi-2,2-dimetilpropil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[1-(metil sulfonil) piperidin-3-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi benzamid; N-[(4- {[(1-acetilpiperidin-3-il) metil] amino}-3-nitrofenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3R)-1-(metil sulfonil) pirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-3,3-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetra hidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({1-[2-fluoro-1-(fluorometil) etil] azetidin-3-il} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[1-(metilsulfonil) pirolidin-3-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(4- {[(1-acetilpirolidin-3-il) metil] amino}-3-nitrofenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(4-{[(3R)-1-acetilpirolidin-3-il] amino}-3-nitrofenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetil cikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(3-metoksi-2,2-dimetilpropil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[(1R,3R)-3-hidroksiciklopentil] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[(1S,3S)-3-hidroksiciklopentil] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[(1S,3R)-3-hidroksiciklopentil] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[(1R,3S)-3-hidroksiciklopentil] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(3S)-2-oksopiperidin-3-il] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[({1-[2-fluoro-1-(fluorometil) etil] azetidin-3-il} metil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(1-oksetan-3-ilazetidin-3-il) metil] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(1-oksetan-3-ilpiperidin-4-il) metil] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(1-ciklopropil piperidin-4-il) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[4-(2-fluoroetil) morfolin-2-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[4-(2,2-difluoro etil) morfolin-2-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-fluoro-1-oksetan-3-ilpiperidin-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(2S)-4,4-di fluoro-1-oksetan-3-ilpirolidin-2-il] metoksi}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(4-tetrahidro-2H-piran-4-ilmorfolin-3-il) metil] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(4-ciklobutil morfolin-3-il) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(4-tetrahidrofuran-3-ilmorfolin-3-il) metil] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[({1-[2-fluoro-1-(fluorometil) etil] piperidin-4-il} metil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1-ciklopropil-4-fluoropiperidin-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-metoksi benzil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[3-(tri fluorometoksi) benzil] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(3-metoksi benzil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[4-(difluoro metoksi) benzil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-(1,4-dioksa spiro[4.5]dec-8-ilamino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-N-[(4-{[4-(acetilamino)cikloheksil] amino}-3-nitrofenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3R)-1-(2,2-difluoroetil) pirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[[(3S)-1-(2-fluoroetil) pirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3S)-1-(2,2-difluoroetil) pirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3R)-1-(2-fluoroetil) pirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(3S)-1-oksetan-3-ilpirolidin-3-il] metoksi} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-hidroksi benzil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(3-hidroksi benzil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[3-(difluoro metoksi) benzil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[cis-3-morfolin-4-ilciklopentil] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({4-[(metilsulfonil) amino] cikloheksil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1-ciklopropil piperidin-4-il) amino]-3-[(trifluorometil) sulfonil] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(1-oksetan-3-ilpiperidin-4-il) metoksi] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-fluoro-1-tetrahidro-2H-piran-4-ilpiperidin-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-fluoro-1-tetrahidrofuran-3-ilpiperidin-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[4-fluoro-1-(metilsulfonil) piperidin-4-il] metoksi}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[3-nitro-4-({[(3R)-1-oksetan-3-ilpirolidin-3-il] metil} amino) fenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-hidroksi cikloheksil) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({4-[3-(dimetil amino) propoksi] benzil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[4-(2-morfolin-4-iletoksi) benzil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[(E)-4-hidroksi-1-adamantil] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[(Z)-4-hidroksi-1-adamantil] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({4-[(1S,4S)-biciklo[2.2.1]hept-5-en-2-ilmetoksi]-3-nitrofenil} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1-metil-5-oksopirolidin-3-il) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(1R,4R,5R, 6S)-5,6-dihidroksibiciklo[2.2.1]hept-2-il] metoksi}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(1R,4R, 5S,6R)-5,6-dihidroksibiciklo[2.2.1]hept-2-il] metoksi}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(3-oksocikloheksil) metoksi] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-5,5-dimetilcikloheksa-1,3-dien-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({(3R)-1-[2-fluoro-1-(fluorometil) etil] pirolidin-3-il} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[6-[(4-fluoro tetrahidro-2H-piran-4-il) metoksi]-5-(trifluorometil) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[3-nitro-4-({[(3S)-1-oksetan-3-ilpirolidin-3-il] metil} amino) fenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-N-({5-hloro-6-[(4-metoksicikloheksil) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Cis-N-({5-hloro-6-[(4-metoksicikloheksil) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(3S)-1-oksetan-3-ilpirolidin-3-il] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[({4-[2-(2-metoksietoksi) etil] morfolin-2-il} metil) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[4-(cijano metil) morfolin-2-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[4-(N,N-di metilglicil) morfolin-2-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; (2-{[(4-{[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzoil] sulfamoil}-2-nitrofenil) amino] metil} morfolin-4-il) sirćetna kiselina; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[3-nitro-4-({[4-(oksetan-3-il) morfolin-2-il] metil} amino) fenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(4-ciklopropil morfolin-2-il) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[5-(metilsulfonil)-6-(tetrahidro-2H-piran-4-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-fluorotetra hidro-2H-piran-4-il) metoksi]-3-[(trifluorometil) sulfonil] fenil} sulfonil)-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-metiltetra hidro-2H-piran-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; etil 4-(4-{[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzoil] sulfamoil}-2-nitrofenil) piperazin-1-karboksilat; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[4-(morfolin-4-il)piperidin-1-il]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[(3R)-1-(oksetan-3-il) pirolidin-3-il] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3R)-1-(1,3-difluoropropan-2-il) pirolidin-3-il] amino}-3-[(trifluorometil) sulfonil] fenil) sulfonil]-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(1-izopropil piperidin-4-il) amino]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({4-[(1-terc-butilpiperidin-4-il) amino]-3-nitrofenil} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetil cikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[1-(2-metoksi etil) piperidin-3-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[1-(cijano metil) piperidin-3-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-fluoro-1-metil piperidin-4-il) metoksi]-3-[(trifluorometil) sulfonil] fenil} sulfonil)-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(3R)-1-(1,3-difluoropropan-2-il) pirolidin-3-il] amino} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; terc-butil 4-[(4-{[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzoil] sulfamoil}-2-nitrofenil) amino] piperazin-1-karboksilat; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-(pentafluoro-λ6-sulfanil)-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-metoksi tetrahidro-2H-piran-4-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3R)-1-(1,3-difluoropropan-2-il) pirolidin-3-il] oksi}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[4-(oksetan-3-il) piperazin-1-il] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[4-(tetrahidro-2H-piran-4-il) piperazin-1-il] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(3R)-tetrahidrofuran-3-ilamino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(4,4-difluoro cikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({4-[(-terc-butilpiperidin-4-il) amino]-3-[(trifluorometil) sulfonil] fenil} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-({[4-(oksetan-3-il) morfolin-2-il] metil} amino)-3-[(trifluorometil) sulfonil] fenil} sulfonil)-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(4-fluorotetrahidro-2H-piran-4-il) metil] amino} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(1-ciklopropilpiperidin-4-il) amino] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(2S)-4-(cijanometil) morfolin-2-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(2S)-4-(N,N-dimetilglicil) morfolin-2-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(2R)-4-(cijanometil) morfolin-2-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(2R)-4-(N,N-dimetilglicil) morfolin-2-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({5-nuoro-6-[(4-fluorotetrahidro-2H-piran-4-il) metoksi] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[3-hidroksi-2-(hidroksimetil)-2-metilpropoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({6-[(4-fluorotetra hidro-2H-piran-4-il) metoksi] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[4-(1,3-di nuoropropan-2-il) morfolin-2-il] metil} amino)-3-nitrofenil] sulfonil-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[1-(cijanometil) piperidin-4-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({(3R)-1-[2-(2-metoksietoksi) etil] pirolidin-3-il} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3R)-1-(N,N-dimetilglicil) pirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-nitro-4-{[1-(oksetan-3-il) azetidin-3-il] amino} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[1-(cijanometil)-4-fluoropiperidin-4-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[(2R)-4-(N,N-dimetilglicil) morfolin-2-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[(2S)-4-(N,N-dimetilglicil) morfolin-2-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[1-(N,N-dimetilglicil) piperidin-4-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(3R)-1-(2,2-difluoroetil) pirolidin-3-il] oksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(3R)-1-(cijanometil) pirolidin-3-il] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-{4-[(4’-hlorobifenil-2-il) metil]-4-metoksipiperidin-1-il}-N-({5-hloro-6-[(4-fluorotetrahidro-2H-piran-4-il) metoksi] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-{4-[(4’-hlorobifenil-2-il) metil]-4-metoksipiperidin-1-il}-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[9-(4-hlorofenil)-3-(1,3-difluoropropan-2-il)-3-azaspiro[5.5]undec-8-en-8-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[9-(4-hlorofenil)-3-izopropil-3-azaspiro[5.5]undec-8-en-8-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[9-(4-hlorofenil)-3-(1,3-difluoropropan-2-il)-3-azaspiro[5.5]undec-8-en-8-il] metil} piperazin-1-il)-N-{[5-hloro-6-(tetrahidro-2H-piran-4-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[9-(4-hlorofenil)-3-izopropil-3-azaspiro[5.5]undec-8-en-8-il] metil} piperazin-1-il)-N-{[5-hloro-6-(tetrahidro-2H-piran-4-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(4-fluoro-1-metilpiperidin-4-il) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[1-(N,N-dimetilglicil)-4-fluoropiperidin-4-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-{4-[(4’-hlorobifenil-2-il) metil]-4-fluoropiperidin-1-il}-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-{4-[(4’-hlorobifenil-2-il) metil]-4-fluoropiperidin-1-il}-N-({5-hloro-6-[(4-fluorotetrahidro-2H-piran-4-il) metoksi] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[9-(4-hlorofenil)-3-izopropil-3-azaspiro[5.5]undec-8-en-8-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi)-N-({4-[(tetrahidro-2H-piran-4-ilmetil) amino]-3-(trifluoro metil) fenil} sulfonil) benzamid; N-[(5-hloro-6-{[(3R)-1-(1,3-difluoropropan-2-il) pirolidin-3-il] oksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[2-(tetrahidrofuran-3-iloksi) etoksi] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(trans-4-cijanocikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[4-fluoro-1-(oksetan-3-il) piperidin-4-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({5-cijano-6-[2-(tetrahidro-2H-piran-4-il) etoksi] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-(3-furil metoksi)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(3R)-1-(1,3-difluoropropan-2-il) pirolidin-3-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(3R)-1-(2,2-difluoroetil) pirolidin-3-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[1-(1,3-difluoropropan-2-il)-4-fluoropiperidin-4-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({3-hloro-4-[(4-fluoro-1-metilpiperidin-4-il) metoksi] fenil} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[3-cijano-4-(tetrahidro-2H-piran-4-ilmetoksi) fenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[1-(2,2-difluoroetil)-4-fluoropiperidin-4-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({3-hloro-4-[(4-fluorotetrahidro-2H-piran-4-il) metoksi] fenil} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(4,4-difluorocikloheksil) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[6-{[1-(1,3-di fluoropropan-2-il)-4-fluoropiperidin-4-il] metoksi}-5-(trifluorometil) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({5-hloro-6-[2-(tetrahidrofuran-2-il) etoksi] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil}-3-metilpiperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[3-(ciklopro pilamino) propil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-{[5-hloro-6-(2-metoksietoksi) piridin-3-il] sulfonil}-4-(4-{[2-(4-hlorofenil)-4,4-dimetilciklo heks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[5-fluoro-6-(tetra hidro-2Hpiran-4-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(3-hloro-4-{[1-(metoksiacetil) piperidin-4-il] metoksi} fenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(3-hloro-4-{[1-(N,N-dimetilglicil) piperidin-4-il] metoksi} fenil) sulfonil]-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; Trans-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheksil] metil} piperidin-1-il)-N-({3-nitro-4-[(tetra hidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi)-N-{[6-(tetrahidro-2H-piran-4-ilmetoksi)-5-(trifluorometil) piridin-3-il] sulfonil} benzamid; N-({5-hloro-6-[(trans-4-hidroksicikloheksil) metoksi] piridin-3-il}sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-cijano-4-[(4-fluorotetrahidro-2H-piran-4-il) metoksi] fenil} sulfonil)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({6-[(trans-4-metoksicikloheksil) metoksi]-5-(trifluorometil) piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({6-[(cis-4-metoksicikloheksil) metoksi]-5-(trifluorometil) piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(4,4-difluoro-1-hidroksicikloheksil) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperidin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(3-hloro-4-{[trans-4-(morfolin-4-il) cikloheksil] metoksi} fenil) sulfonil]-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({3-[ciklopropil (1,3-tiazol-5-ilmetil) amino] propil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({3-hloro-4-[(trans-4-hidroksicikloheksil) metoksi] fenil} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-hloro-4-[(tetra hidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-fluorotetra hidro-2H-piran-4-il) metoksi]-3-(trifluorometil) fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({3-[ciklopropil (2,2,2-trifluoroetil) amino] propil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(3-hloro-4-{[1-(oksetan-3-il) piperidin-4-il] metoksi} fenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3,5-difluoro-4-[(4-fluorotetrahidro-2H-piran-4-il) metoksi] fenil} sulfonil)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({3-[ciklopropil (oksetan-3-il) amino] propil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(3-hloro-4-{[1-(1-metil-L-prolil) piperidin-4-il] metoksi} fenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3,4-difluoro-5-[(4-fluorotetrahidro-2H-piran-4-il) metoksi] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(2S)-4-ciklopropilmorfolin-2-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperidin-1-il)-N-({3-nitro-4-[(tetra hidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperidin-1-il)-N-{[3-hloro-4-(tetra hidro-2H-piran-4-ilmetoksi) fenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; metil 2-{[(4-{[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzoil] sulfamoil}-2-nitrofenil) amino] metil} morfoline-4-karboksilat; 2- {[(4-{[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzoil] sulfamoil}-2-nitrofenil) amino] metil}-N-etil-N-metilmorfoline-4-karboksamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[4-(metil sulfonil) morfolin-2-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({3-[ciklobutil (ciklopropil) amino] propil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-5,5-difluorocikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetra hidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(3-hloro-4-{[4-fluoro-1-(oksetan-3-il) piperidin-4-il] metoksi} fenil) sulfonil]-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[3-hloro-4-(tetrahidro furan-3-ilmetoksi) fenil]sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-5,5-difluorocikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(trans-4-hidroksicikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({3-hloro-4-[(4-fluorotetrahidro-2H-piran-4-il) metoksi] fenil} sulfonil)-4-(4-{[9-(4-hlorofenil)-3-(oksetan-3-il)-3-azaspiro[5.5]undec-8-en-8-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[(2R)-4-ciklo propilmorfolin-2-il] metil} amino)-3-nitrofenil] sulfonil{-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[(2S)-4-ciklo propilmorfolin-2-il] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[5-(4-hlorofenil) spiro[2.5]oct-5-en-6-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-{[5-hloro-6-({4-[ciklopropil(oksetan-3-il) amino] cikloheksil} metoksi) piridin-3-il] sulfonil}-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[5-(4-hlorofenil) spiro[2.5]oct-5-en-6-il] metil} piperazin-1-il)-N-[(4-{[(4-ciklopropil morfolin-2-il) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({3-hloro-4-[(4-ciklopropilmorfolin-2-il) metoksi] fenil} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(3-hloro-4-{[(4-ciklopropilmorfolin-2-il) metil] amino} fenil) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 2-{[(2-hloro-4-{[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzoil] sulfamoil} fenil) amino] metil}-N-etil-N-metilmorfolin-4-karboksamid; (2S)-2-{[(3-hloro-5-{[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzoil] sulfamoil} piridin-2-il) oksi] metil}-N-etil-N-metilmorfolin-4-karboksamid; N-[(5-hloro-6-{[(4-ciklopropilmorfolin-2-il) metil] amino} piridin-3-il) sulfonil]-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 2-1[(3-hloro-5-{[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzoil] sulfamoil} piridin-2-il) amino] metil}-N-etil-N-metilmorfolin-4-karboksamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(trans-4-hidroksi-4-metilcikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(cis-4-hidroksi-4-metilcikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(1R,2R,4R,5R)-5-hidroksi-5-metilbiciklo[2.2.1]hept-2-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({4-[(2-cijano etil) (ciklopropil) amino] cikloheksil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(trans-4-hidroksi-4-metilcikloheksil) metoksi] piridin-3-il} sulfonil)-4-(4-{[5-(4-hlorofenil) spiro[2.5]oct-5-en-6-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[5-hloro-6-(5,6, 7,8-tetrahidroimidazo[1,2-a]piridin-6-ilmetoksi) piridin-3-il] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[(1R,2S,4R,5R)-5-hidroksi-5-metilbiciklo[2.2.1]hept-2-il] metoksi{piridin-3-il) sulfonil]-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il]metil}piperazin-1-il)-N-({4-[(cis-4-hidroksi-4-metilcikloheksil) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-[(5-hloro-6-{[4-fluoro-1-(oksetan-3-il) piperidin-4-il] metoksi} piridin-3-il) sulfonil]-4-(4-{[5-(4-hlorofenil) spiro[2.5]oct-5-en-6-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[4-(3,3-di fluoropirolidin-1-il) cikloheksil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(trans-4-hidroksi-4-metilcikloheksil) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(cis-4-hidroksi-4-metilcikloheksil) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({4-[(2,2-difluorociklopropil) amino] cikloheksil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(cis-1-fluoro-4-hidroksicikloheksil) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[3-nitro-4-(2-oksa spiro[3.5]non-7-ilmetoksi) fenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(trans-4-hidroksi-4-metilcikloheksil) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-5,5-bis(fluorometil) cikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({4-[(4-ciklopropil morfolin-2-il) metoksi]-3-nitrofenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(trans-1-fluoro-4-hidroksi-4-metilcikloheksil) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({5-hloro-6-[(cis-1-fluoro-4-hidroksi-4-metilcikloheksil) metoksi] piridin-3-il} sulfonil)-4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(3-cijano-4-{[4-fluoro-1-(oksetan-3-il)piperidin-4-il] metoksi} fenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(trans-4-etil-4-hidroksicikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(cis-4-etil-4-hidroksicikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-5-(metoksimetil)-5-metilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[3-nitro-4-({[(2S)-4-(oksetan-3-il) morfolin-2-il] metil} amino) fenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-({3-hloro-4-[(trans-4-hidroksi-4-metilcikloheksil) metoksi] fenil} sulfonil)-4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({4-[(2-cijano etil) (ciklopropil) amino]-1-fluorocikloheksil} metoksi)-3-nitrofenil] sulfonil}-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({5-nitro-6-[(tetra hidro-2H-piran-4-ilmetil) amino] piridin-3-il} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(2-oksaspiro[3.5]non-7-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(4-cijano-4-metilcikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo[2,3-b] piridin-5-iloksi)-N-{[3-(tetrahidro-2H-piran-4-ilmetil)-3H-[1,2,3]triazolo[4,5-b]piridin-6-il]sulfonil} benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(6-{[(trans-4-hidroksi-4-metilcikloheksil) metil] amino}-5-nitropiridin-3-il) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(5-cijano-6-{[4-fluoro-1-(oksetan-3-il) piperidin-4-il] metoksi} piridin-3-il) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; N-(4-{[4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-2-(1H-pirolo [2,3-b]piridin-5-iloksi) benzoil] sulfamoil}-2-nitrofenil) morfolin-4-karboksamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-{[4-({[4-(metoksi metil) cikloheksil] metil} amino)-3-nitrofenil] sulfonil}-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(5-hloro-6-{[1-(1,3-tiazol-2-il) piperidin-4-il] metoksi} piridin-3-il) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(6-{[(cis-4-hidroksi-4-metilcikloheksil) metil] amino}-5-nitropiridin-3-il) sulfonil]-2-(1H-pirolo[2,3-b] piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-5-metoksi-5-metilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(trans-4-hidroksi-4-metilcikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; 4-(4-{[2-(4-hlorofenil)-5-metoksi-5-metilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid; ili njegova terapeutski prihvatljiva so.
5. Jedinjenje ili terapeutski prihvatljiva so prema zahtevu 1, koje je 4-(4-{[2-(4-hloro fenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-({3-nitro-4-[(tetrahidro-2H-piran-4-ilmetil) amino] fenil} sulfonil)-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid ili njegova terapeutski prihvatljiva so.
6. Jedinjenje ili terapeutski prihvatljiva so prema zahtevu 1, koje je 4-(4-{[2-(4-hlorofenil)-4,4-dimetilcikloheks-1-en-1-il] metil} piperazin-1-il)-N-[(4-{[(trans-4-hidroksi-4-metilcikloheksil) metil] amino}-3-nitrofenil) sulfonil]-2-(1H-pirolo[2,3-b]piridin-5-iloksi) benzamid ili njegova terapeutski prihvatljiva so.
7. Jedinjenje ili terapeutski prihvatljiva so prema bilo kom od zahteva 1-6 za korišćenje u lečenju kancera bešike, kancera mozga, kancera dojke, kancera koštane srži, hronične limfocitne leukemije, kolorektalnog kancera, ezofagealnog kancera, hepatocelularnog kancera, limfoblastične leukemije, folikularnog limfoma, limfoidne malignosti Tćelijsko ili B-ćelijskog porekla, melanoma, mielogenozne leukemije, oralnog kancera, kancera jajnika, kancera ne-malih ćelija pluća, mieloma, kancera prostate, kancera malih ćelija pluća ili kancera jetre kod pacijenta.
8. Farmaceutska kompozicija koja sadrži ekscipijens i jedinjenje ili terapeutski prihvatljivu so prema bilo kom od zahteva 1-6.
9. Jedinjenje ili teraputski prihvatljiva so prema bilo kom od zahteva 1-6 za korišćenje kao medikamenta. 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18120309P | 2009-05-26 | 2009-05-26 | |
| PCT/US2010/036198 WO2010138588A2 (en) | 2009-05-26 | 2010-05-26 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| EP10721246.6A EP2435432B3 (en) | 2009-05-26 | 2010-05-26 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME02205B true ME02205B (me) | 2016-02-20 |
Family
ID=42677657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2015-124A ME02205B (me) | 2009-05-26 | 2010-05-26 | INDUKUJUĆI AGENSI APOPTOZE ZA LEČENJE KANCERA I IMUNIH l AUTOIMUNIH OBOLJENJA |
Country Status (43)
Families Citing this family (114)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100160322A1 (en) | 2008-12-04 | 2010-06-24 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| US8557983B2 (en) | 2008-12-04 | 2013-10-15 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| EP3666758A1 (en) * | 2008-12-05 | 2020-06-17 | AbbVie Inc. | Process for the preparation of a sulfonamide derivative |
| US8563735B2 (en) | 2008-12-05 | 2013-10-22 | Abbvie Inc. | Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| US8586754B2 (en) | 2008-12-05 | 2013-11-19 | Abbvie Inc. | BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| MX2011007681A (es) * | 2009-01-19 | 2011-08-08 | Abbott Lab | Agentes inducidores de apoptosis para el tratamiento del cancer y enfermedades inmunes y autoinmunes. |
| US8546399B2 (en) * | 2009-05-26 | 2013-10-01 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
| RU2535347C3 (ru) * | 2009-05-26 | 2019-05-14 | ЭббВи Айэленд Анлимитед Компани | Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунных и аутоиммунных заболеваний |
| US9034875B2 (en) | 2009-05-26 | 2015-05-19 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| US20220315555A1 (en) | 2009-05-26 | 2022-10-06 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
| TWI520960B (zh) | 2010-05-26 | 2016-02-11 | 艾伯維有限公司 | 用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑 |
| EA031737B1 (ru) | 2010-06-03 | 2019-02-28 | Фармасайкликс, Инк. | Применение ингибиторов тирозинкиназы брутона (btk) для лечения лейкоза и лимфомы |
| TWI535712B (zh) | 2010-08-06 | 2016-06-01 | 阿斯特捷利康公司 | 化合物 |
| UA113500C2 (xx) * | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
| EP2632436B1 (en) * | 2010-10-29 | 2018-08-29 | Abbvie Inc. | Solid dispersions containing an apoptosis-inducing agent |
| WO2012071336A1 (en) | 2010-11-23 | 2012-05-31 | Abbott Laboratories | Salts and crystalline forms of an apoptosis-inducing agent |
| PT2642999T (pt) * | 2010-11-23 | 2017-01-05 | Abbvie Ireland Unlimited Co | Métodos de tratamento que utilizam inibidores seletivos de bcl-2 |
| WO2012111839A1 (en) | 2011-02-15 | 2012-08-23 | Ube Industries, Ltd. | Industrial methods for producing arylsulfur pentafluorides |
| CN102241649A (zh) * | 2011-07-08 | 2011-11-16 | 陈飞 | 3-四氢呋喃甲醇的制备方法 |
| CN103958508B (zh) | 2011-10-14 | 2019-02-12 | 艾伯维公司 | 用于治疗癌症以及免疫与自身免疫性疾病的细胞凋亡诱导剂 |
| WO2013185202A1 (en) * | 2012-06-14 | 2013-12-19 | Beta Pharma Canada Inc | Apoptosis inducers |
| EP3550031A1 (en) | 2012-07-24 | 2019-10-09 | Pharmacyclics, LLC | Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk) |
| WO2014028381A1 (en) * | 2012-08-13 | 2014-02-20 | Abbvie Inc. | Apoptosis-inducing agents |
| HK1212240A1 (en) | 2012-09-07 | 2016-06-10 | 吉宁特有限公司 | Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor |
| LT6064B (lt) | 2012-10-15 | 2014-08-25 | Vilniaus Universitetas | Fluorinti benzensulfonamidai kaip karboanhidrazės inhibitoriai |
| KR102229478B1 (ko) * | 2012-11-01 | 2021-03-18 | 인피니티 파마슈티칼스, 인코포레이티드 | Pi3 키나아제 동형단백질 조절인자를 사용하는 암의 치료 |
| US20150283142A1 (en) * | 2013-03-15 | 2015-10-08 | Infinity Pharmaceuticals, Inc. | Treatment of cancers using pi3 kinase isoform modulators |
| US9006438B2 (en) | 2013-03-13 | 2015-04-14 | Abbvie Inc. | Processes for the preparation of an apoptosis-inducing agent |
| US20140275082A1 (en) * | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| US20160287592A1 (en) * | 2013-04-08 | 2016-10-06 | Pharmacyclics Llc | Ibrutinib combination therapy |
| TWI594975B (zh) | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
| US9238652B2 (en) | 2014-03-04 | 2016-01-19 | Abbvie Inc. | Processes for the preparation of an apoptosis-inducing agent |
| WO2015171591A1 (en) | 2014-05-05 | 2015-11-12 | Board Of Trustees Of The University Of Arkansas | COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS |
| EP3177144A4 (en) | 2014-07-22 | 2018-01-24 | Bioventures, LLC. | Compositions and methods for selectively depleting senescent cells |
| CN104163798A (zh) * | 2014-07-29 | 2014-11-26 | 苏州康润医药有限公司 | 3-氨基-8-三氟甲基喹啉的合成方法 |
| RS62713B1 (sr) | 2014-08-11 | 2022-01-31 | Acerta Pharma Bv | Terapeutske kombinacije btk inhibitora i bcl-2 inhibitora |
| AU2015328174B2 (en) | 2014-10-06 | 2020-05-21 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator |
| US10195213B2 (en) | 2015-03-13 | 2019-02-05 | Unity Biotechnology, Inc. | Chemical entities that kill senescent cells for use in treating age-related disease |
| WO2017007846A1 (en) | 2015-07-07 | 2017-01-12 | Genentech, Inc. | Combination therapy with an anti-her2 antibody-drug conjugate and a bcl-2 inhibitor |
| WO2017063572A1 (zh) * | 2015-10-13 | 2017-04-20 | 苏州晶云药物科技有限公司 | 细胞凋亡诱导剂的新晶型及其制备方法 |
| ES2959692T3 (es) | 2015-12-04 | 2024-02-27 | Alexion Pharma Inc | Cerdulatinib y venetoclax para tratar linfoma no Hodgkin |
| WO2017156398A1 (en) | 2016-03-10 | 2017-09-14 | Assia Chemical Industries Ltd. | Solid state forms of venetoclax and processes for preparation of venetoclax |
| CA3253937A1 (en) | 2016-03-15 | 2025-03-04 | Oryzon Genomics, S.A. | Combinations of Lysine-Specific Demethylase 1 Inhibitors for the Treatment of Hematological Maligna |
| US11027021B2 (en) | 2016-03-15 | 2021-06-08 | Seagen Inc. | Combinations of PBD-based antibody drug conjugates with Bcl-2 inhibitors |
| EA201892075A1 (ru) | 2016-03-15 | 2019-04-30 | Оризон Дженомикс, С.А. | Комбинации ингибиторов lsd1 для применения для лечения солидных опухолей |
| AU2017240685B2 (en) | 2016-03-31 | 2021-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator |
| KR102447884B1 (ko) | 2016-04-21 | 2022-09-27 | 바이오벤처스, 엘엘씨 | 항-세포자멸적 bcl-2 계열 단백질의 열화를 유도하는 화합물 및 이의 용도 |
| JP6651180B2 (ja) * | 2016-08-05 | 2020-02-19 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガンThe Regents Of The University Of Michigan | Bcl−2阻害剤としてのn−(フェニルスルホニル)ベンズアミドおよび関連化合物 |
| CN109641897B (zh) * | 2016-09-01 | 2021-12-07 | 北京赛林泰医药技术有限公司 | Bcl-2选择性抑制剂及其制备和用途 |
| JOP20190042B1 (ar) | 2016-09-30 | 2021-08-17 | Vertex Pharma | مُعدِّل لمنظم موصلية التليف الكيسي عبر الغشاء، وتركيبات صيدلانية، وطرق للعلاج، وعملية لتصنيع المُعدِّل |
| CN106749233B (zh) * | 2016-11-24 | 2020-04-21 | 中山大学 | 一类磺酰胺衍生物及其应用 |
| PL3689868T3 (pl) | 2016-12-01 | 2024-03-11 | Arvinas Operations, Inc. | Pochodne tetrahydronaftalenu i tetrahydroizochinoliny jako degradery receptorów estrogenowych |
| JOP20190125B1 (ar) | 2016-12-09 | 2022-03-14 | Vertex Pharma | مُعدِّل لمنظم موصلية التليف الكيسي عبر الغشاء، وتركيبات صيدلانية، وطرق للعلاج، وعملية لتصنيع المُعدِّل |
| CN110177788B (zh) * | 2017-01-07 | 2023-03-24 | 重庆复创医药研究有限公司 | 作为bcl-2选择性凋亡诱导剂的化合物 |
| JOP20190191A1 (ar) | 2017-02-22 | 2019-08-08 | Astrazeneca Ab | وحدات شجرية علاجية |
| WO2018167652A1 (en) * | 2017-03-13 | 2018-09-20 | Laurus Labs Limited | Process for preparation of amorphous form of venetoclax |
| WO2018192462A1 (en) * | 2017-04-18 | 2018-10-25 | Shanghai Fochon Pharmaceutical Co., Ltd. | Apoptosis-inducing agents |
| CN107089981A (zh) * | 2017-04-24 | 2017-08-25 | 杭州科耀医药科技有限公司 | 一种BCL‑2抑制剂Venetoclax的合成方法 |
| EP3634402A1 (en) | 2017-06-08 | 2020-04-15 | Vertex Pharmaceuticals Incorporated | Methods of treatment for cystic fibrosis |
| EP3626241B1 (en) * | 2017-06-26 | 2025-04-23 | Shenzhen TargetRx, Inc. | Deuterated n-benzenesulfonylbenzamide compound for inhibiting bcl-2 protein and composition and use thereof |
| AU2018304168B2 (en) | 2017-07-17 | 2023-05-04 | Vertex Pharmaceuticals Incorporated | Methods of treatment for cystic fibrosis |
| CN110869391A (zh) | 2017-07-26 | 2020-03-06 | 豪夫迈·罗氏有限公司 | 用BET抑制剂,Bcl-2抑制剂和抗CD20抗体的组合疗法 |
| JP2020528418A (ja) | 2017-07-26 | 2020-09-24 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | BET阻害剤及びBcl−2阻害剤を用いた併用療法 |
| US11434201B2 (en) | 2017-08-02 | 2022-09-06 | Vertex Pharmaceuticals Incorporated | Processes for preparing pyrrolidine compounds |
| CN116621860A (zh) | 2017-08-23 | 2023-08-22 | 广州麓鹏制药有限公司 | Bcl-2抑制剂 |
| US10654829B2 (en) | 2017-10-19 | 2020-05-19 | Vertex Pharmaceuticals Incorporated | Crystalline forms and compositions of CFTR modulators |
| CN108037196B (zh) * | 2017-11-23 | 2020-06-23 | 中山奕安泰医药科技有限公司 | 一种3-硝基-4-[[(四氢-2h-吡喃-4-基)甲基]氨基]苯磺酰胺的检测方法 |
| CA3085006A1 (en) | 2017-12-08 | 2019-06-13 | Vertex Pharmaceuticals Incorporated | Processes for making modulators of cystic fibrosis transmembrane conductance regulator |
| WO2019139902A1 (en) | 2018-01-10 | 2019-07-18 | Zeno Royalties & Milestones, LLC | Benzamide compounds |
| CA3088253A1 (en) | 2018-01-22 | 2019-07-25 | Bioventures, Llc | Bcl-2 proteins degraders for cancer treatment |
| TWI810243B (zh) | 2018-02-05 | 2023-08-01 | 美商維泰克斯製藥公司 | 用於治療囊腫纖化症之醫藥組合物 |
| US20190336496A1 (en) | 2018-02-16 | 2019-11-07 | Abbvie Inc. | Selective bcl-2 inhibitors in combination with an anti-pd-1 or an anti-pd-l1 antibody for the treatment of cancers |
| TW202002952A (zh) | 2018-03-15 | 2020-01-16 | 美商艾伯維有限公司 | 用於治療胰臟癌之abbv-621與抗癌劑之組合 |
| CN111868059B (zh) * | 2018-03-30 | 2021-12-03 | 正大天晴药业集团股份有限公司 | 三氟甲基取代的磺酰胺类选择性bcl-2抑制剂 |
| EP3774825A1 (en) | 2018-04-13 | 2021-02-17 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
| JP2021521138A (ja) | 2018-04-29 | 2021-08-26 | ベイジーン リミテッド | Bcl−2阻害剤 |
| TW202014412A (zh) | 2018-05-04 | 2020-04-16 | 美商普托拉製藥有限公司 | 賽度替尼(cerdulatinib)之固體型式 |
| US12084423B2 (en) | 2018-05-18 | 2024-09-10 | Bioventures, Llc | Piperlongumine analogues and uses thereof |
| WO2020023435A1 (en) | 2018-07-24 | 2020-01-30 | Albany Molecular Research, Inc. | Venetoclax basic salts and processes for the purification of venetoclax |
| TW202023568A (zh) | 2018-07-30 | 2020-07-01 | 瑞典商阿斯特捷利康公司 | 用於治療癌症之組合療法 |
| CN110772521A (zh) | 2018-07-31 | 2020-02-11 | 苏州亚盛药业有限公司 | Bcl-2抑制剂或Bcl-2/Bcl-xL抑制剂与BTK抑制剂的组合产品及其用途 |
| MX2020009759A (es) * | 2018-07-31 | 2020-10-08 | Ascentage Pharma Suzhou Co Ltd | Efecto antitumoral sinergico de un inhibidor de bcl-2 combinado con rituximab y/o bendamustina o un inhibidor de bcl-2 combinado con chop. |
| AU2019314624B2 (en) | 2018-07-31 | 2022-03-03 | Ascentage Pharma (Suzhou) Co., Ltd. | Combination product of Bcl-2 inhibitor and MDM2 inhibitor and use thereof in the prevention and/or treatment of diseases |
| CA3095699A1 (en) | 2018-07-31 | 2020-02-06 | Ascentage Pharma (Suzhou) Co., Ltd. | Combination product of bcl-2 inhibitor and chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases |
| US11903950B2 (en) | 2018-08-22 | 2024-02-20 | Newave Pharmaceutical Inc. | BCL-2 inhibitors |
| EP3858832A4 (en) * | 2018-10-29 | 2022-06-08 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | TRIFLUOROMETHYL-SUBSTITUTED SULFONAMIDE AS BCL-2 SELECTIVE INHIBITOR |
| CN109438441A (zh) * | 2018-11-30 | 2019-03-08 | 重庆三圣实业股份有限公司 | 一种维奈妥拉的制备方法及其产品 |
| CN109320516A (zh) * | 2018-11-30 | 2019-02-12 | 重庆三圣实业股份有限公司 | 一种维奈妥拉中间体的制备方法及其产品 |
| WO2020232214A1 (en) | 2019-05-14 | 2020-11-19 | Abbvie Inc. | Treating acute myeloid leukemia (aml) with mivebresib, a bromodomain inhibitor |
| WO2020234445A1 (en) | 2019-05-23 | 2020-11-26 | F. Hoffmann-La Roche Ag | Combination therapy with a bet inhibitor and a bcl-2 inhibitor |
| US12319689B2 (en) | 2019-05-24 | 2025-06-03 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitor |
| MX2022002415A (es) | 2019-08-26 | 2022-03-22 | Arvinas Operations Inc | Metodos de tratamiento del cancer de mama con derivados de tetrahidronaftaleno como degradadores del receptor de estrogenos. |
| WO2021037933A1 (en) | 2019-08-28 | 2021-03-04 | Astrazeneca Ab | Combination of azd2811 nanoparticles, 5-azacitidine and venetoclax for use in the treatment of cancer |
| CN112661751B (zh) * | 2019-10-16 | 2024-06-14 | 南京天印健华医药科技有限公司 | 作为bcl-2抑制剂的杂环化合物 |
| WO2021083135A1 (en) * | 2019-10-28 | 2021-05-06 | Beigene, Ltd. | Bcl-2 INHIBITORS |
| WO2021110102A1 (en) * | 2019-12-02 | 2021-06-10 | Beigene, Ltd. | Methods of cancer treatment using bcl-2 inhibitor |
| AU2021256580A1 (en) | 2020-04-15 | 2022-09-29 | Beone Medicines I Gmbh | Bcl-2 inhibitor |
| EP4129998A4 (en) * | 2020-04-29 | 2024-05-01 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Crystal of trifluoromethyl/chloro disubstituted sulfonamide selective bcl-2 inhibitor |
| CN111848607B (zh) * | 2020-07-22 | 2023-03-17 | 长沙创新药物工业技术研究院有限公司 | 一种新型bcl-2/bcl-xl抑制剂、药物组合物及用途 |
| CN114057728A (zh) * | 2020-08-06 | 2022-02-18 | 北京诺诚健华医药科技有限公司 | 作为bcl-2抑制剂的杂环化合物 |
| US20230398110A1 (en) * | 2020-08-21 | 2023-12-14 | Ascentage Pharma (Suzhou) Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
| WO2022089463A1 (zh) * | 2020-10-28 | 2022-05-05 | 杭州和正医药有限公司 | Bcl-2蛋白凋亡诱导剂及应用 |
| CN114736203A (zh) * | 2021-01-07 | 2022-07-12 | 南京天印健华医药科技有限公司 | 作为bcl-2抑制剂的杂环化合物 |
| CA3211639A1 (en) * | 2021-03-19 | 2022-09-22 | Volodymyr KYSIL | Compounds having ((3-nitrophenyl)sulfonyl)acetamide as bcl-2 inhibitors |
| WO2022218311A1 (en) * | 2021-04-13 | 2022-10-20 | Appicine Therapeutics (Hk) Limited | Modulators of bcl-2 or bcl-2/bcl-xl and uses thereof |
| CN117377672A (zh) | 2021-06-04 | 2024-01-09 | 正大天晴药业集团股份有限公司 | 三氟甲基取代的磺酰胺类化合物的磷酸酯 |
| WO2023030363A1 (en) * | 2021-08-31 | 2023-03-09 | Beigene, Ltd. | Solid forms of bcl-2 inhibitors, method of preparation, and use thereof |
| IT202100025976A1 (it) | 2021-10-06 | 2023-04-06 | Univ Degli Studi Di Perugia | Combinazione di principi attivi per il trattamento della leucemia acuta mieloide (LAM) con mutazione della nucleofosmina (NPM1) |
| CN118660886A (zh) | 2021-12-09 | 2024-09-17 | 佛罗里达大学研究基金公司 | 用于治疗癌症的bcl-xl/bcl-2双重降解剂 |
| WO2024012557A1 (en) * | 2022-07-15 | 2024-01-18 | Berrybio (Hong Kong) Limited | Anti-apoptotic bcl-2 family protein degraders, pharmaceutical compositions, and therapeutic applications |
| IL318494A (en) * | 2022-07-21 | 2025-03-01 | Beigene Switzerland Gmbh | Methods for treating multiple myeloma using a BCL-2 inhibitor |
| CN115260191B (zh) * | 2022-09-29 | 2022-12-27 | 上海睿跃生物科技有限公司 | 哌啶类化合物及其制备方法和应用 |
| KR102598137B1 (ko) | 2022-11-24 | 2023-11-06 | 율촌화학 주식회사 | 고차단성 생분해 필름 및 이의 제조방법 |
| EP4421075A1 (en) | 2023-02-27 | 2024-08-28 | KRKA, d.d., Novo mesto | Process for the preparation of venetoclax and intermediates used therein |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2579596B1 (fr) * | 1985-03-26 | 1987-11-20 | Inst Nat Sante Rech Med | (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique |
| CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| CA2016710A1 (en) * | 1989-05-15 | 1990-11-15 | Prasun K. Chakravarty | Substituted benzimidazoles as angiotensin ii antagonists |
| GB9110625D0 (en) * | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Chemical compounds |
| AU673569B2 (en) * | 1992-12-02 | 1996-11-14 | Pfizer Inc. | Catechol diethers as selective PDE-IV inhibitors |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| DK1019385T3 (da) | 1995-09-15 | 2004-05-24 | Upjohn Co | Aminoaryloxazolidinon-N-oxider |
| CA2305414A1 (en) * | 1997-10-03 | 1999-04-15 | Merck Frosst Canada & Co. | Aryl thiophene derivatives as pde iv inhibitors |
| US20030220234A1 (en) | 1998-11-02 | 2003-11-27 | Selvaraj Naicker | Deuterated cyclosporine analogs and their use as immunodulating agents |
| ES2318899T3 (es) * | 1998-07-06 | 2009-05-01 | Bristol-Myers Squibb Company | Bifenil sulfonamidas como antagonistas duales de los receptores de angiotensina y endotelina. |
| DE19830430A1 (de) * | 1998-07-08 | 2000-01-13 | Hoechst Marion Roussel De Gmbh | Schwefelsubstituierte Sulfonylamino-carbonsäure-N-arylamide, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| GB9918037D0 (en) | 1999-07-30 | 1999-09-29 | Biochemie Gmbh | Organic compounds |
| AU776933B2 (en) * | 1999-12-28 | 2004-09-23 | Eisai R&D Management Co., Ltd. | Heterocyclic compounds having sulfonamide groups |
| GB2361003A (en) * | 2000-04-07 | 2001-10-10 | Astrazeneca Ab | Novel compounds |
| US6720338B2 (en) | 2000-09-20 | 2004-04-13 | Abbott Laboratories | N-acylsulfonamide apoptosis promoters |
| UY26942A1 (es) * | 2000-09-20 | 2002-04-26 | Abbott Lab | N-acilsulfonamidas promotoras de la apoptosis |
| US20020055631A1 (en) | 2000-09-20 | 2002-05-09 | Augeri David J. | N-acylsulfonamide apoptosis promoters |
| US6995162B2 (en) | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
| SK14642003A3 (sk) | 2001-06-06 | 2004-12-01 | Eli Lilly And Company | Benzoylsulfónamidy a sulfonylbenzamidíny ako protinádorové činidlá |
| US20030059489A1 (en) | 2001-09-24 | 2003-03-27 | Canolio Inc. | Genital lubricating compositions and uses thereof |
| EP1429759A4 (en) * | 2001-09-26 | 2004-12-15 | Bristol Myers Squibb Co | COMPOUNDS FOR TREATING HEPATITIS C VIRUS |
| FR2836914B1 (fr) * | 2002-03-11 | 2008-03-14 | Aventis Pharma Sa | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
| GB0215650D0 (en) * | 2002-07-05 | 2002-08-14 | Cyclacel Ltd | Bisarylsufonamide compounds |
| US6995787B2 (en) | 2002-08-21 | 2006-02-07 | Adams Steven L | Sports projectile and camera apparatus |
| WO2005024636A1 (ja) | 2003-09-04 | 2005-03-17 | Hitachi Ulsi Systems Co., Ltd. | 半導体装置 |
| WO2005049593A2 (en) | 2003-11-13 | 2005-06-02 | Abbott Laboratories | N-acylsulfonamide apoptosis promoters |
| US7973161B2 (en) * | 2003-11-13 | 2011-07-05 | Abbott Laboratories | Apoptosis promoters |
| US7767684B2 (en) | 2003-11-13 | 2010-08-03 | Abbott Laboratories | Apoptosis promoters |
| US8614318B2 (en) | 2003-11-13 | 2013-12-24 | Abbvie Inc. | Apoptosis promoters |
| US7642260B2 (en) | 2003-11-13 | 2010-01-05 | Abbott Laboratories, Inc. | Apoptosis promoters |
| WO2005099353A2 (en) | 2004-04-19 | 2005-10-27 | Symed Labs Limited | A novel process for the preparation of linezolid and related compounds |
| ES2382383T3 (es) * | 2004-06-17 | 2012-06-07 | Infinity Discovery, Inc. | Compuestos y procedimientos para inhibir la interacción de proteínas Bcl con componentes de unión |
| PL1768967T3 (pl) | 2004-07-20 | 2009-09-30 | Symed Labs Ltd | Nowe związki pośrednie do wytwarzania linezolidu oraz związki pokrewne |
| US7361764B2 (en) * | 2004-07-27 | 2008-04-22 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
| JP2008514702A (ja) | 2004-09-29 | 2008-05-08 | エーエムアール テクノロジー インコーポレイテッド | 新規シクロスポリン類似体およびそれらの薬学的使用 |
| US8624027B2 (en) | 2005-05-12 | 2014-01-07 | Abbvie Inc. | Combination therapy for treating cancer and diagnostic assays for use therein |
| CA2606147C (en) | 2005-05-12 | 2011-07-05 | Abbott Laboratories | Apoptosis promoters |
| US20080300267A1 (en) * | 2005-05-16 | 2008-12-04 | Barun Okram | Compounds and Compositions as Protein Kinase Inhibitors |
| TW200716636A (en) | 2005-05-31 | 2007-05-01 | Speedel Experimenta Ag | Heterocyclic spiro-compounds |
| PL1893612T3 (pl) * | 2005-06-22 | 2012-01-31 | Plexxikon Inc | Pochodne pirolo-[2,3-b]pirydyny jako inhibitory kinazy białkowej |
| US7514068B2 (en) | 2005-09-14 | 2009-04-07 | Concert Pharmaceuticals Inc. | Biphenyl-pyrazolecarboxamide compounds |
| US20070115787A1 (en) * | 2005-11-23 | 2007-05-24 | Seagate Technology Llc | Planar optical device for generating optical nanojets |
| JP5277168B2 (ja) | 2006-09-05 | 2013-08-28 | アボット・ラボラトリーズ | 血小板過剰を治療するbclインヒビター |
| US8796267B2 (en) | 2006-10-23 | 2014-08-05 | Concert Pharmaceuticals, Inc. | Oxazolidinone derivatives and methods of use |
| WO2008064116A2 (en) | 2006-11-16 | 2008-05-29 | Abbott Laboratories | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
| MX2009008465A (es) | 2007-02-15 | 2009-08-20 | Hoffmann La Roche | Nuevas 2-aminooxazolinas como ligandos de taar1. |
| US8536157B2 (en) | 2007-04-13 | 2013-09-17 | The University Of Melbourne | Non-steroidal compounds |
| CA2686545C (en) | 2007-04-19 | 2010-11-02 | Concert Pharmaceuticals Inc. | Deuterated morpholinyl compounds |
| US7531685B2 (en) | 2007-06-01 | 2009-05-12 | Protia, Llc | Deuterium-enriched oxybutynin |
| WO2009035598A1 (en) | 2007-09-10 | 2009-03-19 | Concert Pharmaceuticals, Inc. | Deuterated pirfenidone |
| US20090118238A1 (en) | 2007-09-17 | 2009-05-07 | Protia, Llc | Deuterium-enriched alendronate |
| US20090082471A1 (en) | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched fingolimod |
| US20090088416A1 (en) | 2007-09-26 | 2009-04-02 | Protia, Llc | Deuterium-enriched lapaquistat |
| US20090137457A1 (en) | 2007-10-02 | 2009-05-28 | Concert Pharmaceuticals, Inc. | Pyrimidinedione derivatives |
| US20090098118A1 (en) * | 2007-10-15 | 2009-04-16 | Thomas Friess | Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent |
| US8410124B2 (en) | 2007-10-18 | 2013-04-02 | Concert Pharmaceuticals Inc. | Deuterated etravirine |
| US20090105338A1 (en) | 2007-10-18 | 2009-04-23 | Protia, Llc | Deuterium-enriched gabexate mesylate |
| WO2009055006A1 (en) | 2007-10-26 | 2009-04-30 | Concert Pharmaceuticals, Inc. | Deuterated darunavir |
| US8168784B2 (en) * | 2008-06-20 | 2012-05-01 | Abbott Laboratories | Processes to make apoptosis promoters |
| UA108193C2 (uk) * | 2008-12-04 | 2015-04-10 | Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань | |
| US8557983B2 (en) | 2008-12-04 | 2013-10-15 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| US20100160322A1 (en) | 2008-12-04 | 2010-06-24 | Abbott Laboratories | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| US8563735B2 (en) | 2008-12-05 | 2013-10-22 | Abbvie Inc. | Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| EP3666758A1 (en) * | 2008-12-05 | 2020-06-17 | AbbVie Inc. | Process for the preparation of a sulfonamide derivative |
| US8586754B2 (en) | 2008-12-05 | 2013-11-19 | Abbvie Inc. | BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| WO2010077740A2 (en) | 2008-12-09 | 2010-07-08 | Cytokine Pharmasciences, Inc. | Novel antiviral compounds, compositions, and methods of use |
| WO2010072734A2 (en) | 2008-12-23 | 2010-07-01 | The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | Targeting prodrugs and compositions for the treatment of gastrointestinal diseases |
| CN104945311A (zh) | 2009-01-19 | 2015-09-30 | Abbvie公司 | 用于治疗癌症和免疫和自身免疫疾病的细胞程序死亡诱导药剂 |
| MX2011007681A (es) * | 2009-01-19 | 2011-08-08 | Abbott Lab | Agentes inducidores de apoptosis para el tratamiento del cancer y enfermedades inmunes y autoinmunes. |
| RU2535347C3 (ru) * | 2009-05-26 | 2019-05-14 | ЭббВи Айэленд Анлимитед Компани | Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунных и аутоиммунных заболеваний |
| US8546399B2 (en) | 2009-05-26 | 2013-10-01 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
| TWI520960B (zh) * | 2010-05-26 | 2016-02-11 | 艾伯維有限公司 | 用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑 |
-
2010
- 2010-05-26 RU RU2011152973A patent/RU2535347C3/ru active Protection Beyond IP Right Term
- 2010-05-26 KR KR1020187032920A patent/KR102001418B1/ko active Active
- 2010-05-26 CA CA3206963A patent/CA3206963A1/en active Pending
- 2010-05-26 PL PL10721246.6T patent/PL2435432T6/pl unknown
- 2010-05-26 CA CA2929347A patent/CA2929347A1/en not_active Abandoned
- 2010-05-26 SG SG10201704742YA patent/SG10201704742YA/en unknown
- 2010-05-26 KR KR1020117030916A patent/KR101659583B1/ko active Active
- 2010-05-26 PE PE2011002025A patent/PE20120345A1/es active IP Right Grant
- 2010-05-26 CN CN201910270919.5A patent/CN109966294A/zh active Pending
- 2010-05-26 IL IL299019A patent/IL299019A/en unknown
- 2010-05-26 UA UAA201115309A patent/UA106079C2/uk unknown
- 2010-05-26 IL IL319747A patent/IL319747A/en unknown
- 2010-05-26 KR KR1020157014221A patent/KR101723378B1/ko active Active
- 2010-05-26 DK DK10721246.6T patent/DK2435432T6/da active
- 2010-05-26 KR KR1020237028352A patent/KR20230128571A/ko active Pending
- 2010-05-26 CA CA2759182A patent/CA2759182C/en active Active
- 2010-05-26 CN CN201510165051.4A patent/CN104876927B/zh active Active
- 2010-05-26 KR KR1020177008201A patent/KR20170037683A/ko not_active Abandoned
- 2010-05-26 KR KR1020197020313A patent/KR20190086591A/ko not_active Abandoned
- 2010-05-26 PT PT107212466T patent/PT2435432E/pt unknown
- 2010-05-26 CN CN201080023068.1A patent/CN102448959B/zh active Active
- 2010-05-26 CN CN201910261444.3A patent/CN109897038B/zh active Active
- 2010-05-26 AU AU2010254160A patent/AU2010254160C1/en active Active
- 2010-05-26 BR BR122019016429-0A patent/BR122019016429B1/pt active IP Right Grant
- 2010-05-26 CN CN201510215766.6A patent/CN104906100A/zh active Pending
- 2010-05-26 RS RS20150592A patent/RS54234B2/sr unknown
- 2010-05-26 JP JP2012513209A patent/JP5747025B2/ja active Active
- 2010-05-26 MY MYPI2011005633A patent/MY155645A/en unknown
- 2010-05-26 PH PH1/2015/500297A patent/PH12015500297B1/en unknown
- 2010-05-26 SG SG2011075843A patent/SG175253A1/en unknown
- 2010-05-26 UY UY0001032668A patent/UY32668A/es active IP Right Grant
- 2010-05-26 HU HUE10721246A patent/HUE027698T2/en unknown
- 2010-05-26 AR ARP100101806A patent/AR076705A1/es active IP Right Grant
- 2010-05-26 BR BRPI1014359-9A patent/BRPI1014359B1/pt active IP Right Grant
- 2010-05-26 CR CR20170019A patent/CR20170019A/es unknown
- 2010-05-26 EP EP10721246.6A patent/EP2435432B3/en active Active
- 2010-05-26 NZ NZ595708A patent/NZ595708A/en unknown
- 2010-05-26 EP EP19195104.5A patent/EP3656771A1/en not_active Withdrawn
- 2010-05-26 ME MEP-2015-124A patent/ME02205B/me unknown
- 2010-05-26 RU RU2014132884/04A patent/RU2573832C2/ru active
- 2010-05-26 TW TW104138114A patent/TWI561523B/zh active
- 2010-05-26 HR HRP20151001TT patent/HRP20151001T4/hr unknown
- 2010-05-26 MX MX2011012257A patent/MX339469B/es active IP Right Grant
- 2010-05-26 TW TW099116922A patent/TWI476195B/zh active
- 2010-05-26 CA CA3052016A patent/CA3052016A1/en not_active Abandoned
- 2010-05-26 ES ES10721246T patent/ES2546294T7/es active Active
- 2010-05-26 KR KR1020187011857A patent/KR101920202B1/ko active Active
- 2010-05-26 KR KR1020197033737A patent/KR20190130676A/ko active Pending
- 2010-05-26 SI SI201031011T patent/SI2435432T2/sl unknown
- 2010-05-26 TW TW103138402A patent/TWI537269B/zh active
- 2010-05-26 EP EP24195253.0A patent/EP4474383A3/en active Pending
- 2010-05-26 EP EP15167892.7A patent/EP2944638A1/en not_active Withdrawn
- 2010-05-26 WO PCT/US2010/036198 patent/WO2010138588A2/en not_active Ceased
- 2010-11-22 US US12/951,344 patent/US8580794B2/en active Active
- 2010-11-23 UY UY0001033047A patent/UY33047A/es not_active Application Discontinuation
-
2011
- 2011-10-09 IL IL215644A patent/IL215644A/en active IP Right Grant
- 2011-11-17 MX MX2019012154A patent/MX2019012154A/es unknown
- 2011-11-22 CL CL2011002949A patent/CL2011002949A1/es unknown
- 2011-11-23 ZA ZA2011/08616A patent/ZA201108616B/en unknown
- 2011-11-25 CR CR20110632A patent/CR20110632A/es unknown
- 2011-11-25 DO DO2011000367A patent/DOP2011000367A/es unknown
- 2011-12-26 CO CO11178424A patent/CO6480950A2/es not_active Application Discontinuation
- 2011-12-26 EC EC2011011554A patent/ECSP11011554A/es unknown
-
2015
- 2015-01-09 JP JP2015003098A patent/JP6038195B2/ja active Active
- 2015-09-23 CY CY20151100832T patent/CY1117423T1/el unknown
- 2015-09-24 SM SM201500225T patent/SMT201500225B/xx unknown
- 2015-12-18 RU RU2015154494A patent/RU2628885C2/ru active
-
2016
- 2016-03-25 HK HK16103532.1A patent/HK1215576A1/en unknown
- 2016-10-31 JP JP2016212548A patent/JP6353506B2/ja active Active
-
2017
- 2017-05-16 HU HUS1700021C patent/HUS1700021I1/hu unknown
- 2017-05-16 NL NL300873C patent/NL300873I2/nl unknown
- 2017-05-18 LT LTPA2017015C patent/LTC2435432I2/lt unknown
- 2017-05-25 CY CY2017019C patent/CY2017019I1/el unknown
- 2017-05-29 NO NO2017023C patent/NO2017023I2/no unknown
- 2017-05-29 FI FIEP10721246.6T patent/FI2435432T6/fi active
- 2017-08-07 IL IL253891A patent/IL253891A0/en unknown
- 2017-10-18 AR ARP170102895A patent/AR109974A2/es active IP Right Grant
-
2018
- 2018-04-18 JP JP2018079598A patent/JP2018138577A/ja not_active Ceased
- 2018-07-31 UY UY0001037825A patent/UY37825A/es active IP Right Grant
-
2019
- 2019-09-03 IL IL26909219A patent/IL269092A/en unknown
- 2019-10-17 JP JP2019189974A patent/JP2020023545A/ja not_active Ceased
-
2021
- 2021-09-01 IL IL286036A patent/IL286036A/en unknown
- 2021-12-09 JP JP2021199837A patent/JP2022033939A/ja not_active Ceased
-
2023
- 2023-01-10 JP JP2023001499A patent/JP2023040165A/ja active Pending
-
2025
- 2025-02-10 JP JP2025019817A patent/JP2025072583A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME02205B (me) | INDUKUJUĆI AGENSI APOPTOZE ZA LEČENJE KANCERA I IMUNIH l AUTOIMUNIH OBOLJENJA | |
| JP2012528178A5 (me) | ||
| JP2019038820A5 (me) | ||
| RU2497822C2 (ru) | Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний | |
| JP2016517406A5 (me) | ||
| JP2017048219A5 (me) | ||
| RU2015143917A (ru) | Индуцирующие апоптоз средства для лечения злокачественной опухоли и иммунологических и аутоиммунных заболеваний | |
| RU2012127760A (ru) | Bcl-2-селективные апоптоз-индуцирующие средства для лечения рака и иммунных заболеваний | |
| RU2011127232A (ru) | Апоптоз-индуцирующие средства для лечения рака и иммунных и аутоиммунных заболеваний | |
| JP2013512900A5 (me) | ||
| RU2012127790A (ru) | Индуцирующие апоптоз агенты для лечения рака и иммунных и аутоиммунных заболеваний | |
| RU2347777C2 (ru) | Двойные агонисты nk1/nk3 для лечения шизофрении | |
| JP2015526441A5 (me) | ||
| JP2017504631A5 (me) | ||
| JP2013512899A5 (me) | ||
| JP2013531070A5 (me) | ||
| HRP20150925T1 (hr) | Agensi koji induciraju apoptozu za lijeäśenje raka te imunih i autoimunih bolesti | |
| RU2015108894A (ru) | СОЕДИНЕНИЯ 4-ГЕТЕРОАРИЛЗАМЕЩЕННОЙ БЕНЗОЙНОЙ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ RORгаммаТ И ИХ ПРИМЕНЕНИЯ | |
| JP2014523851A5 (me) | ||
| RU2017146661A (ru) | Замещенные пиридины и способ их применения | |
| JP2013528204A5 (me) | ||
| JP2012530765A5 (me) | ||
| JP2013527202A5 (me) | ||
| JP2011515462A5 (me) | ||
| JP2013540823A5 (me) |